Condensed-cyclic compound and organic light-emitting device including the same

ABSTRACT

A condensed cyclic compound and an organic light-emitting device, the compound being represented by Formula 1: 
       (A 1 ) a1 -(L 1 ) b1 -(A 2 ) a2   &lt;Formula 1&gt;
         wherein, in Formula 1, A 1  is a group represented by Formula 2-1, below, a1 is 1, 2, or 3, and, when a1 is 2 or greater, two or more A 1 s are identical to or different from each other, A 2  is a group represented by Formula 2-2, below, a2 is 1, 2, or 3, and, when a2 is 2 or greater, two or more A 2 s are identical to or different from each other,

CROSS-REFERENCE TO RELATED APPLICATION

Korean Patent Application No. 10-2014-0177821, filed on Dec. 10, 2014,in the Korean Intellectual Property Office, and entitled:“Condensed-Cyclic Compound and Organic Light-Emitting Device Includingthe Same,” is incorporated by reference herein in its entirety.

BACKGROUND

1. Field

Embodiments relate to a condensed cyclic compound and an organiclight-emitting device including the condensed cyclic compound.

2. Description of the Related Art

Organic light-emitting devices (OLEDs) are self-emission devices thathave wide viewing angles, high contrast ratios, and short responsetimes. In addition, the OLEDs exhibit excellent luminance, drivingvoltage, and response speed characteristics and produce full-colorimages.

An organic light-emitting device may include a first electrode on asubstrate, and a hole transport region, an emission layer, an electrontransport region, and a second electrode, which are sequentially on thefirst electrode. Holes provided from the first electrode may move towardthe emission layer through the hole transport region, and electronsprovided from the second electrode may move toward the emission layerthrough the electron transport region. The holes and the electrons maybe recombined in the emission layer to produce excitons. These excitonschange from an excited state to a ground state, thereby generatinglight.

SUMMARY

Embodiments are directed to a condensed cyclic compound and an organiclight-emitting device including the condensed cyclic compound.

According to one or more exemplary embodiments, a condensed cycliccompound is represented by Formula 1:

(A₁)_(a1)-(L₁)_(b1)-(A₂)_(a2)  <Formula 1>

wherein, in Formulae 1, 2-1, and 2-2,

A₁ is a group represented by Formula 2-1, a1 is 1, 2, or 3, and, when a1is 2 or greater, two or more A₁ s are identical to or different fromeach other,

A₂ is a group represented by Formula 2-2, a2 is 1, 2, or 3, and, when a2is 2 or greater, two or more A₂s are identical to or different from eachother,

L₁ and L₂ are each independently selected from a substituted orunsubstituted C₃-C₁₀ cycloalkylene group, a substituted or unsubstitutedC₁-C₁₀ heterocycloalkylene group, a substituted or unsubstituted C₃-C₁₀cycloalkenylene group, a substituted or unsubstituted C₁-C₁₀heterocycloalkenylene group, a substituted or unsubstituted C₆-C₆₀arylene group, a substituted or unsubstituted C₁-C₆₀ heteroarylenegroup, a substituted or unsubstituted divalent non-aromatic condensedpolycyclic group, and a substituted or unsubstituted divalentnon-aromatic condensed heteropolycyclic group, where L₂ is not asubstituted or unsubstituted triphenylenylene group,

b1 and b2 are each independently selected from 0, 1, 2, and 3; when b1or b2 is 0, *-(L₁)_(b1)-*′ or *-(L₂)_(b2)-*′ is a single bond, when b1is 2 or greater, two or more L₁s are identical to or different from eachother, and when b2 is 2 or greater, two or more L₂s are identical to ordifferent from each other,

Ar₁ is selected from a substituted or unsubstituted C₃-C₁₀ cycloalkylgroup, a substituted or unsubstituted C₁-C₁₀ heterocycloalkyl group, asubstituted or unsubstituted C₃-C₁₀) cycloalkenyl group, a substitutedor unsubstituted C₁-C₁₀ heterocycloalkenyl group, a substituted orunsubstituted C₆-C₆₀ aryl group, a substituted or unsubstituted C₁-C₆₀heteroaryl group, a substituted or unsubstituted monovalent non-aromaticcondensed polycyclic group, and a substituted or unsubstitutedmonovalent non-aromatic condensed heteropolycyclic group, where Ar₁ isnot a substituted or unsubstituted triphenylenyl group,

R₁ to R₁₂ and R₂₁ to R₃₂ are each independently selected from a bindingsite to one of A₁, L₁, and A₂ in Formula 1, a hydrogen, a deuterium, —F,—Cl, —Br, —I, a hydroxyl group, a cyano group, a nitro group, an aminogroup, an amidino group, a hydrazine group, a hydrazone group, acarboxylic acid or a salt thereof, a sulfonic acid or a salt thereof, aphosphoric acid or a salt thereof, a substituted or unsubstituted C₁-C₆₀alkyl group, a substituted or unsubstituted C₂-C₆₀ alkenyl group, asubstituted or unsubstituted C₂-C₆₀ alkynyl group, a substituted orunsubstituted C₁-C₆₀ alkoxy group, a substituted or unsubstituted C₃-C₁₀cycloalkyl group, a substituted or unsubstituted C₁-C₁₀ heterocycloalkylgroup, a substituted or unsubstituted C₃-C₁₀ cycloalkenyl group, asubstituted or unsubstituted C₁-C₁₀ heterocycloalkenyl group, asubstituted or unsubstituted C₆-C₆₀ aryl group, a substituted orunsubstituted C₆-C₆₀ aryloxy group, a substituted or unsubstitutedC₆-C₆₀ arylthio group, a substituted or unsubstituted C₁-C₆₀ heteroarylgroup, a substituted or unsubstituted monovalent non-aromatic condensedpolycyclic group, a substituted or unsubstituted monovalent non-aromaticcondensed heteropolycyclic group, —Si(Q₁)(Q₂)(Q₃), —B(Q₄)(Q₅), andN(Q₆)(Q₇), where a1 of R₁ to R₁₂ are each independently a binding siteto L₁ or A₂ in Formula 1, and a2 of R₂₁ to R₃₂ are each independently abinding site to L₁ or A₂ in Formula 1;

at least one substituent of the substituted C₃-C₁₀ cycloalkylene group,substituted C₁-C₁₀ heterocycloalkylene group, substituted C₃-C₁₀cycloalkenylene group, substituted C₁-C₁₀ heterocycloalkenylene group,substituted C₆-C₆₀ arylene group, substituted C₁-C₆₀ heteroarylenegroup, substituted divalent non-aromatic condensed polycyclic group,substituted divalent non-aromatic condensed heteropolycyclic group,substituted C₁-C₆₀ alkyl group, substituted C₂-C₆₀ alkenyl group,substituted C₂-C₆₀ alkynyl group, substituted C₁-C₆₀ alkoxy group,substituted C₃-C₁₀ cycloalkyl group, substituted C₁-C₁₀ heterocycloalkylgroup, substituted C₃-C₁₀ cycloalkenyl group, substituted C₁-C₁₀heterocycloalkenyl group, substituted C₆-C₆₀ aryl group, substitutedC₆-C₆₀ aryloxy group, substituted C₆-C₆₀ arylthio group, substitutedC₁-C₆₀ heteroaryl group, substituted monovalent non-aromatic condensedpolycyclic group, and substituted monovalent non-aromatic condensedheteropolycyclic group is selected from

a deuterium, —F, —Cl, —Br, —I, a hydroxyl group, a cyano group, a nitrogroup, an amino group, an amidino group, a hydrazine group, a hydrazonegroup, a carboxylic acid or a salt thereof, a sulfonic acid or a saltthereof, a phosphoric acid or a salt thereof, a C₁-C₆₀ alkyl group, aC₂-C₆₀ alkenyl group, a C₂-C₆₀ alkynyl group, and a C₁-C₆₀ alkoxy group;

a C₁-C₆₀ alkyl group, a C₂-C₆₀ alkenyl group, a C₂-C₆₀ alkynyl group,and a C₁-C₆₀ alkoxy group, each substituted with at least one selectedfrom a deuterium, —F, —Cl, —Br, —I, a hydroxyl group, a cyano group, anitro group, an amino group, an amidino group, a hydrazine group, ahydrazone group, a carboxylic acid or a salt thereof, a sulfonic acid ora salt thereof, a phosphoric acid or a salt thereof, a C₃-C₁₀ cycloalkylgroup, a C₁-C₁₀ heterocycloalkyl group, a C₃-C₁₀ cycloalkenyl group, aC₁-C₁₀ heterocycloalkenyl group, a C₆-C₆₀ aryl group, a C₆-C₆₀ aryloxygroup, a C₆-C₆₀ arylthio group, a C₁-C₆₀ heteroaryl group, a monovalentnon-aromatic condensed polycyclic group, a monovalent non-aromaticcondensed heteropolycyclic group, —Si(Q₁₁)(Q₁₂)(Q₁₃), —B(Q₁₄)(Q₁₅), and—N(Q₁₆)(Q₁₇);

a C₃-C₁₀ cycloalkyl group, a C₁-C₁₀ heterocycloalkyl group, a C₃-C₁₀cycloalkenyl group, a C₁-C₁₀ heterocycloalkenyl group, a C₆-C₆₀ arylgroup, a C₆-C₆₀ aryloxy group, a C₆-C₆₀ arylthio group, a C₁-C₆₀heteroaryl group, a monovalent non-aromatic condensed polycyclic group,and a monovalent non-aromatic condensed heteropolycyclic group;

a C₃-C₁₀ cycloalkyl group, a C₁-C₁₀ heterocycloalkyl group, a C₃-C₁₀cycloalkenyl group, a C₁-C₁₀ heterocycloalkenyl group, a C₆-C₆₀ arylgroup, a C₆-C₆₀ aryloxy group, a C₆-C₆₀ arylthio group, a C₁-C₆₀heteroaryl group, a monovalent non-aromatic condensed polycyclic group,and a monovalent non-aromatic condensed heteropolycyclic group, eachsubstituted with at least one selected from a deuterium, —F, —Cl, —Br,—I, a hydroxyl group, a cyano group, a nitro group, an amino group, anamidino group, a hydrazine group, a hydrazone group, a carboxylic acidor a salt thereof, a sulfonic acid or a salt thereof, a phosphoric acidor a salt thereof, a C₁-C₆₀ alkyl group, a C₂-C₆₀ alkenyl group, aC₂-C₆₀ alkynyl group, a C₁-C₆₀ alkoxy group, a C₃-C₁₀ cycloalkyl group,a C₁-C₁₀ heterocycloalkyl group, a C₃-C₁₀ cycloalkenyl group, a C₁-C₁₀heterocycloalkenyl group, a C₆-C₆₀ aryl group, a C₆-C₆₀ aryloxy group, aC₆-C₆₀ arylthio group, a C₁-C₆₀ heteroaryl group, a monovalentnon-aromatic condensed polycyclic group, a monovalent non-aromaticcondensed heteropolycyclic group, —Si(Q₂₁)(Q₂₂)(Q₂₃), —B(Q₂₄)(Q₂₅), and—N(Q₂₆)(Q₂₇); and

—Si(Q₃₁)(Q₃₂)(Q₃₃), —B(Q₃₄)(Q₃₅), and —N(Q₃₆)(Q₃₇);

wherein Q₁ to Q₇, Q₁₁ to Q₁₇, Q₂₁ to Q₂₇, and Q₃₁ to Q₃₇ are eachindependently selected from a hydrogen, a deuterium, —F, —Cl, —Br, —I, ahydroxyl group, a cyano group, a nitro group, an amino group, an amidinogroup, a hydrazine group, a hydrazone group, a carboxylic acid or a saltthereof, a sulfonic acid or a salt thereof, a phosphoric acid or a saltthereof, a C₁-C₆₀ alkyl group, a C₂-C₆₀ alkenyl group, a C₂-C₆₀ alkynylgroup, a C₁-C₆₀ alkoxy group, a C₃-C₁₀ cycloalkyl group, a C₁-C₁₀heterocycloalkyl group, a C₃-C₁₀ cycloalkenyl group, a C₁-C₁₀heterocycloalkenyl group, a C₆-C₆₀ aryl group, a C₁-C₆₀ heteroarylgroup, a monovalent non-aromatic condensed polycyclic group, and amonovalent non-aromatic condensed heteropolycyclic group.

According to one or more exemplary embodiments, an organiclight-emitting device includes a first electrode; a second electrodefacing the first electrode; and an organic layer that is disposedbetween the first electrode and the second electrode and includes anemission layer, wherein the organic layer includes at least one type ofthe condensed cyclic compound.

BRIEF DESCRIPTION OF THE DRAWING

Features will be apparent to those of skill in the art by describing indetail exemplary embodiments with reference to the attached drawing inwhich:

FIG. 1 illustrates a schematic view of a structure of an organiclight-emitting device according to an exemplary embodiment.

DETAILED DESCRIPTION

Example embodiments will now be described more fully hereinafter withreference to the accompanying drawing; however, they may be embodied indifferent forms and should not be construed as limited to theembodiments set forth herein. Rather, these embodiments are provided sothat this disclosure will be thorough and complete, and will fullyconvey exemplary implementations to those skilled in the art.

In the drawing FIGURE, the dimensions of layers and regions may beexaggerated for clarity of illustration. Like reference numerals referto like elements throughout.

As used herein, the term “and/or” includes any and all combinations ofone or more of the associated listed items. Expressions such as “atleast one of,” when preceding a list of elements, modify the entire listof elements and do not modify the individual elements of the list.

According to one or more exemplary embodiments, a condensed cycliccompound may be represented by Formula 1.

(A₁)_(a1)-(L₁)_(b1)-(A₂)_(a2)  <Formula 1>

In Formula 1, A₁ may be a group represented by Formula 2-1, and A₂ maybe a group represented by Formula 2-2.

In Formula 1, a1 denotes the number of A₁s, and a2 denotes the number ofA₂s, where a1 and a2 may each independently be selected from 1, 2, and3, and when a1 is 2 or greater, two or more A₁s may be identical to ordifferent from each other, and when a2 is 2 or greater, two or more A₂smay be identical to or different from each other.

In some embodiments, in Formula 1, a1 and a2 may each independently be 1or 2.

In some embodiments, in Formula 1, a1 and a2 may each independently be 1or 2, and a1+a2 may be 3.

In some embodiments, in Formula 1, a1 and a2 each be 1.

In Formulae 1 and 2-1, L₁ and L₂ may each independently be selected fromor include, e.g., a substituted or unsubstituted C₃-C₁₀ cycloalkylenegroup, a substituted or unsubstituted C₁-C₁₀ heterocycloalkylene group,a substituted or unsubstituted C₃-C₁₀ cycloalkenylene group, asubstituted or unsubstituted C₁-C₁₀ heterocycloalkenylene group, asubstituted or unsubstituted C₆-C₆₀ arylene group, a substituted orunsubstituted C₁-C₆₀ heteroarylene group, a substituted or unsubstituteddivalent non-aromatic condensed polycyclic group, and a substituted orunsubstituted divalent non-aromatic condensed heteropolycyclic group. Inan implementation, L₂ may not be a substituted or unsubstitutedtriphenylenylene group.

In some embodiments, in Formulae 1 and 2-1, L₁ and L₂ may eachindependently be selected from, e.g.,

a phenylene group, a pentalenylene group, an indenylene group, anaphthylene group, an azulenylene group, a heptalenylene group, anindacenylene group, an acenaphthylene group, a fluorenylene group, aspiro-fluorenylene group, a benzofluorenylene group, adibenzofluorenylene group, a phenalenylene group, a phenanthrenylenegroup, an anthracenylene group, a fluoranthenylene group, a pyrenylenegroup, a chrysenylene group, a naphthacenylene group, a picenylenegroup, a perylenylene group, a pentaphenylene group, a hexacenylenegroup, a pentacenylene group, a rubicenylene group, a coronenylenegroup, an ovalenylene group, a pyrrolylene group, a thiophenylene group,a furanylene group, an imidazolylene group, a pyrazolylene group, athiazolylene group, an isothiazolylene group, an oxazolylene group, anisoxazolylene group, a pyridinylene group, a pyrazinylene group, apyrimidinylene group, a pyridazinylene group, an isoindolylene group, anindolylene group, an indazolylene group, a purinylene group, aquinolinylene group, an isoquinolinylene group, a benzoquinolinylenegroup, a phthalazinylene group, a naphthyridinylene group, aquinoxalinylene group, a quinazolinylene group, a cinnolinylene group, acarbazolylene group, a phenanthridinylene group, an acridinylene group,a phenanthrolinylene group, a phenazinylene group, a benzoimidazolylenegroup, a benzofuranylene group, a benzothiophenylene group, anisobenzothiazolylene group, a benzoxazolylene group, anisobenzoxazolylene group, a triazolylene group, a tetrazolylene group,an oxadiazolylene group, a triazinylene group, a dibenzofuranylenegroup, a dibenzothiophenylene group, a benzocarbazolylene group, adibenzocarbazolylene group, a thiadiazolylene group, animidazopyridinylene group, and an imidazopyrimidinylene group; and

a phenylene group, a pentalenylene group, an indenylene group, anaphthylene group, an azulenylene group, a heptalenylene group, anindacenylene group, an acenaphthylene group, a fluorenylene group, aspiro-fluorenylene group, a benzofluorenylene group, adibenzofluorenylene group, a phenalenylene group, a phenanthrenylenegroup, an anthracenylene group, a fluoranthenylene group, a pyrenylenegroup, a chrysenylene group, a naphthacenylene group, a picenylenegroup, a perylenylene group, a pentaphenylene group, a hexacenylenegroup, a pentacenylene group, a rubicenylene group, a coronenylenegroup, an ovalenylene group, a pyrrolylene group, a thiophenylene group,a furanylene group, an imidazolylene group, a pyrazolylene group, athiazolylene group, an isothiazolylene group, an oxazolylene group, anisoxazolylene group, a pyridinylene group, a pyrazinylene group, apyrimidinylene group, a pyridazinylene group, an isoindolylene group, anindolylene group, an indazolylene group, a purinylene group, aquinolinylene group, an isoquinolinylene group, a benzoquinolinylenegroup, a phthalazinylene group, a naphthyridinylene group, aquinoxalinylene group, a quinazolinylene group, a cinnolinylene group, acarbazolylene group, a phenanthridinylene group, an acridinylene group,a phenanthrolinylene group, a phenazinylene group, a benzoimidazolylenegroup, a benzofuranylene group, a benzothiophenylene group, anisobenzothiazolylene group, a benzoxazolylene group, anisobenzoxazolylene group, a triazolylene group, a tetrazolylene group,an oxadiazolylene group, a triazinylene group, a dibenzofuranylenegroup, a dibenzothiophenylene group, a benzocarbazolylene group, adibenzocarbazolylene group, a thiadiazolylene group, animidazopyridinylene group, and an imidazopyrimidinylene group, eachsubstituted with at least one selected from a deuterium, —F, —Cl, —Br,—I, a hydroxyl group, a cyano group, a nitro group, an amino group, anamidino group, a hydrazine group, a hydrazone group, a carboxylic acidor a salt thereof, a sulfonic acid or a salt thereof, a phosphoric acidor a salt thereof, a C₁-C₂₀ alkyl group, a C₁-C₂₀ alkoxy group, acyclopentyl group, a cyclohexyl group, a cycloheptyl group, acyclopentenyl group, a cyclohexenyl group, a phenyl group, a pentalenylgroup, an indenyl group, a naphthyl group, an azulenyl group, aheptalenyl group, an indacenyl group, an acenaphthyl group, a fluorenylgroup, a spiro-fluorenyl group, a benzofluorenyl group, adibenzofluorenyl group, a phenalenyl group, a phenanthrenyl group, ananthracenyl group, a fluoranthenyl group, a pyrenyl group, a chrysenylgroup, a naphthacenyl group, a picenyl group, a perylenyl group, apentaphenyl group, a hexacenyl group, a pentacenyl group, a rubicenylgroup, a coronenyl group, an ovalenyl group, a pyrrolyl group, athiophenyl group, a furanyl group, an imidazolyl group, a pyrazolylgroup, a thiazolyl group, an isothiazolyl group, an oxazolyl group, anisoxazolyl group, a pyridinyl group, a pyrazinyl group, a pyrimidinylgroup, a pyridazinyl group, an isoindolyl group, an indolyl group, anindazolyl group, a purinyl group, a quinolinyl group, an isoquinolinylgroup, a benzoquinolinyl group, a phthalazinyl group, a naphthyridinylgroup, a quinoxalinyl group, a quinazolinyl group, a cinnolinyl group, acarbazolyl group, a phenanthridinyl group, an acridinyl group, aphenanthrolinyl group, a phenazinyl group, a benzoimidazolyl group, abenzofuranyl group, a benzothiophenyl group, an isobenzothiazolyl group,a benzoxazolyl group, an isobenzoxazolyl group, a triazolyl group, atetrazolyl group, an oxadiazolyl group, a triazinyl group, adibenzofuranyl group, a dibenzothiophenyl group, a benzocarbazolylgroup, a dibenzocarbazolyl group, a thiadiazolyl group, animidazopyridinyl group, and an imidazopyrimidinyl group.

In one embodiment, L₁ and L₂ may each independently be a grouprepresented by one of the following Formulae 3-1 to 3-38.

In Formulae 3-1 to 3-38,

Y₁ may be O, S, C(Z₃)(Z₄), N(Z₅), or Si(Z₆)(Z₇);

Z₁ to Z₇ may each independently be selected from a hydrogen, adeuterium, —F, —Cl, —Br, —I, a hydroxyl group, a cyano group, a nitrogroup, an amino group, an amidino group, a hydrazine group, a hydrazonegroup, a carboxylic acid or a salt thereof, a sulfonic acid or a saltthereof, a phosphoric acid or a salt thereof, a C₁-C₂₀ alkyl group, aC₁-C₂₀ alkoxy group, a phenyl group, a naphthyl group, a fluorenylgroup, a spiro-fluorenyl group, a benzofluorenyl group, adibenzofluorenyl group, a phenanthrenyl group, an anthracenyl group, apyrenyl group, a chrysenyl group, a pyridinyl group, a pyrazinyl group,a pyrimidinyl group, a pyridazinyl group, a quinolinyl group, anisoquinolinyl group, a quinoxalinyl group, a quinazolinyl group, acarbazolyl group, and a triazinyl group,

d1 may be an integer selected from 1 to 4, d2 may be an integer selectedfrom 1 to 3, d3 may be an integer selected from 1 to 6, d4 may be aninteger selected from 1 to 8, d5 may be an integer of 1 or 2, d6 may bean integer selected from 1 to 5, and * and *′ are each independently abinding site to a neighboring atom.

In one embodiment, L₁ and L₂ may each independently be selected from,e.g.,

a phenylene group, a naphthylene group, a pyridinylene group, apyrimidinylene group, a quinolinylene group, a quinoxalinylene group,and a triazinylene group; and

a phenylene group, a naphthylene group, a pyridinylene group, apyrimidinylene group, a quinolinylene group, a quinoxalinylene group,and a triazinylene group, each substituted with at least one selectedfrom a hydrogen, a deuterium, —F, —Cl, —Br, —I, a hydroxyl group, acyano group, a nitro group, an amino group, an amidino group, ahydrazine group, a hydrazone group, a carboxylic acid or a salt thereof,a sulfonic acid or a salt thereof, a phosphoric acid or a salt thereof,a C₁-C₂₀ alkyl group, a C₁-C₂₀ alkoxy group, a phenyl group, a naphthylgroup, a fluorenyl group, a spiro-fluorenyl group, a benzofluorenylgroup, a dibenzofluorenyl group, a phenanthrenyl group, an anthracenylgroup, a pyrenyl group, a chrysenyl group, a pyridinyl group, apyrazinyl group, a pyrimidinyl group, a pyridazinyl group, a quinolinylgroup, an isoquinolinyl group, a quinoxalinyl group, a quinazolinylgroup, a carbazolyl group, and a triazinyl group, but embodiments arenot limited thereto.

In Formulae 1 and 2-1, b1 denotes the number of L₁s, and b2 denotes thenumber of L₂s, and b1 and b2 may each independently be selected from 0,1, 2, and 3.

When b1 or b2 is 0, *-(L₁)_(b1)-′ or *-(L₂)_(b2)-*′ is a single bond.When b1 is 2 or greater, two or more L₁s may be identical to ordifferent from each other, and when b2 is 2 or greater, two or more L₂smay be identical to or different from each other.

In one embodiment, b1 and b2 may each independently be selected from 0,1, and 2.

In Formula 2-1, Ar₁ may be selected from or include, e.g., a substitutedor unsubstituted C₃-C₁₀ cycloalkyl group, a substituted or unsubstitutedC₁-C₁₀ heterocycloalkyl group, a substituted or unsubstituted C₃-C₁₀cycloalkenyl group, a substituted or unsubstituted C₁-C₁₀heterocycloalkenyl group, a substituted or unsubstituted C₆-C₆₀ arylgroup, a substituted or unsubstituted C₁-C₆₀ heteroaryl group, asubstituted or unsubstituted monovalent non-aromatic condensedpolycyclic group, and a substituted or unsubstituted monovalentnon-aromatic condensed heteropolycyclic group. In an implementation, Ar₁may not be a substituted or unsubstituted triphenylenyl group.

In one embodiment, Ar₁ may be selected from, e.g.,

a phenyl group, a pentalenyl group, an indenyl group, a naphthyl group,an azulenyl group, a heptalenyl group, an indacenyl group, anacenaphthyl group, a fluorenyl group, a spiro-fluorenyl group, abenzofluorenyl group, a dibenzofluorenyl group, a phenalenyl group, aphenanthrenyl group, an anthracenyl group, a fluoranthenyl group, apyrenyl group, a chrysenyl group, a naphthacenyl group, a picenyl group,a perylenyl group, a pentaphenyl group, a hexacenyl group, a pentacenylgroup, a rubicenyl group, a coronenyl group, an ovalenyl group, apyrrolyl group, a thiophenyl group, a furanyl group, an imidazolylgroup, a pyrazolyl group, a thiazolyl group, an isothiazolyl group, anoxazolyl group, an isoxazolyl group, a pyridinyl group, a pyrazinylgroup, a pyrimidinyl group, a pyridazinyl group, an isoindolyl group, anindolyl group, an indazolyl group, a purinyl group, a quinolinyl group,an isoquinolinyl group, a benzoquinolinyl group, a phthalazinyl group, anaphthyridinyl group, a quinoxalinyl group, a quinazolinyl group, acinnolinyl group, a carbazolyl group, a phenanthridinyl group, anacridinyl group, a phenanthrolinyl group, a phenazinyl group, abenzoimidazolyl group, a benzofuranyl group, a benzothiophenyl group, anisobenzothiazolyl group, a benzoxazolyl group, an isobenzoxazolyl group,a triazolyl group, a tetrazolyl group, an oxadiazolyl group, a triazinylgroup, a benzocarbazolyl group, a dibenzocarbazolyl group, athiadiazolyl group, an imidazopyridinyl group, and an imidazopyrimidinylgroup; and

a phenyl group, a pentalenyl group, an indenyl group, a naphthyl group,an azulenyl group, a heptalenyl group, an indacenyl group, anacenaphthyl group, a fluorenyl group, a spiro-fluorenyl group, abenzofluorenyl group, a dibenzofluorenyl group, a phenalenyl group, aphenanthrenyl group, an anthracenyl group, a fluoranthenyl group, apyrenyl group, a chrysenyl group, a naphthacenyl group, a picenyl group,a perylenyl group, a pentaphenyl group, a hexacenyl group, a pentacenylgroup, a rubicenyl group, a coronenyl group, an ovalenyl group, apyrrolyl group, a thiophenyl group, a furanyl group, an imidazolylgroup, a pyrazolyl group, a thiazolyl group, an isothiazolyl group, anoxazolyl group, an isoxazolyl group, a pyridinyl group, a pyrazinylgroup, a pyrimidinyl group, a pyridazinyl group, an isoindolyl group, anindolyl group, an indazolyl group, a purinyl group, a quinolinyl group,an isoquinolinyl group, a benzoquinolinyl group, a phthalazinyl group, anaphthyridinyl group, a quinoxalinyl group, a quinazolinyl group, acinnolinyl group, a carbazolyl group, a phenanthridinyl group, anacridinyl group, a phenanthrolinyl group, a phenazinyl group, abenzoimidazolyl group, a benzofuranyl group, a benzothiophenyl group, anisobenzothiazolyl group, a benzoxazolyl group, an isobenzoxazolyl group,a triazolyl group, a tetrazolyl group, an oxadiazolyl group, a triazinylgroup, a benzocarbazolyl group, a dibenzocarbazolyl group, athiadiazolyl group, an imidazopyridinyl group, and an imidazopyrimidinylgroup, each substituted with at least one selected from a deuterium, —F,—Cl, —Br, —I, a hydroxyl group, a cyano group, a nitro group, an aminogroup, an amidino group, a hydrazine group, a hydrazone group, acarboxylic acid or a salt thereof, a sulfonic acid or a salt thereof, aphosphoric acid or a salt thereof, a C₁-C₂₀ alkyl group, a C₁-C₂₀ alkoxygroup, a cyclopentyl group, a cyclohexyl group, a cycloheptyl group, acyclopentenyl group, a cyclohexenyl group, a phenyl group, a pentalenylgroup, an indenyl group, a naphthyl group, an azulenyl group, aheptalenyl group, an indacenyl group, an acenaphthyl group, a fluorenylgroup, a spiro-fluorenyl group, a benzofluorenyl group, adibenzofluorenyl group, a phenalenyl group, a phenanthrenyl group, ananthracenyl group, a fluoranthenyl group, a pyrenyl group, a chrysenylgroup, a naphthacenyl group, a picenyl group, a perylenyl group, apentaphenyl group, a hexacenyl group, a pentacenyl group, a rubicenylgroup, a coronenyl group, an ovalenyl group, a pyrrolyl group, athiophenyl group, a furanyl group, an imidazolyl group, a pyrazolylgroup, a thiazolyl group, an isothiazolyl group, an oxazolyl group, anisoxazolyl group, a pyridinyl group, a pyrazinyl group, a pyrimidinylgroup, a pyridazinyl group, an isoindolyl group, an indolyl group, anindazolyl group, a purinyl group, a quinolinyl group, an isoquinolinylgroup, a benzoquinolinyl group, a phthalazinyl group, a naphthyridinylgroup, a quinoxalinyl group, a quinazolinyl group, a cinnolinyl group, acarbazolyl group, a phenanthridinyl group, an acridinyl group, aphenanthrolinyl group, a phenazinyl group, a benzoimidazolyl group, abenzofuranyl group, a benzothiophenyl group, an isobenzothiazolyl group,a benzoxazolyl group, an isobenzoxazolyl group, a triazolyl group, atetrazolyl group, an oxadiazolyl group, a triazinyl group, abenzocarbazolyl group, a dibenzocarbazolyl group, a thiadiazolyl group,an imidazopyridinyl group, an imidazopyrimidinyl group, and—Si(Q₃₁)(Q₃₂)(Q₃₃).

In one embodiment, Ar₁ may be selected from, e.g.,

a phenyl group, a naphthyl group, a fluorenyl group, a spiro-fluorenylgroup, a benzofluorenyl group, a dibenzofluorenyl group, a phenanthrenylgroup, an anthracenyl group, a pyrenyl group, a chrysenyl group, apyridinyl group, a pyrazinyl group, a pyrimidinyl group, a pyridazinylgroup, a quinolinyl group, an isoquinolinyl group, a quinoxalinyl group,a quinazolinyl group, a carbazolyl group, a triazinyl group, abenzocarbazolyl group, and a dibenzocarbazolyl group; and

a phenyl group, a naphthyl group, a fluorenyl group, a spiro-fluorenylgroup, a benzofluorenyl group, a dibenzofluorenyl group, a phenanthrenylgroup, an anthracenyl group, a pyrenyl group, a chrysenyl group, apyridinyl group, a pyrazinyl group, a pyrimidinyl group, a pyridazinylgroup, a quinolinyl group, an isoquinolinyl group, a quinoxalinyl group,a quinazolinyl group, a carbazolyl group, a triazinyl group, abenzocarbazolyl group, and a dibenzocarbazolyl group, each substitutedwith at least one selected from a deuterium, —F, —Cl, —Br, —I, ahydroxyl group, a cyano group, a nitro group, an amino group, an amidinogroup, a hydrazine group, a hydrazone group, a carboxylic acid or a saltthereof, a sulfonic acid or a salt thereof, a phosphoric acid or a saltthereof, a C₁-C₂₀ alkyl group, a C₁-C₂₀ alkoxy group, a phenyl group, anaphthyl group, a fluorenyl group, a spiro-fluorenyl group, abenzofluorenyl group, a dibenzofluorenyl group, a phenanthrenyl group,an anthracenyl group, a pyrenyl group, a chrysenyl group, a pyridinylgroup, a pyrazinyl group, a pyrimidinyl group, a pyridazinyl group, aquinolinyl group, an isoquinolinyl group, a quinoxalinyl group, aquinazolinyl group, a carbazolyl group, a triazinyl group, abenzocarbazolyl group, a dibenzocarbazolyl group, and—Si(Q₃₁)(Q₃₂)(Q₃₃).

In one embodiment, Ar₁ may be a group represented by one of thefollowing Formulae 5-1 to 5-15.

In Formulae 5-1 to 5-15,

Y₃₁ may be C(Z₃₃)(Z₃₄) or N(Z₃₅);

Z₃₁ to Z₃₅ may each independently be selected from:

a hydrogen, a deuterium, —F, —Cl, —Br, —I, a hydroxyl group, a cyanogroup, a nitro group, an amino group, an amidino group, a hydrazinegroup, a hydrazone group, a carboxylic acid or a salt thereof, asulfonic acid or a salt thereof, a phosphoric acid or a salt thereof, aC₁-C₂₀ alkyl group, and a C₁-C₂₀ alkoxy group;

a C₁-C₂₀ alkyl group and a C₁-C₂₀ alkoxy group, each substituted with atleast one selected from a deuterium, —F, —Cl, —Br, —I, a hydroxyl group,a cyano group, a nitro group, an amino group, an amidino group, ahydrazine group, a hydrazone group, a carboxylic acid or a salt thereof,a sulfonic acid or a salt thereof, and a phosphoric acid or a saltthereof;

a phenyl group, a naphthyl group, a fluorenyl group, a spiro-fluorenylgroup, a benzofluorenyl group, a dibenzofluorenyl group, a phenanthrenylgroup, an anthracenyl group, a pyrenyl group, a chrysenyl group, apyridinyl group, a pyrazinyl group, a pyrimidinyl group, a pyridazinylgroup, a quinolinyl group, an isoquinolinyl group, a quinoxalinyl group,a quinazolinyl group, a carbazolyl group, a triazinyl group, abenzocarbazolyl group, and a dibenzocarbazolyl group;

a phenyl group, a naphthyl group, a fluorenyl group, a spiro-fluorenylgroup, a benzofluorenyl group, a dibenzofluorenyl group, a phenanthrenylgroup, an anthracenyl group, a pyrenyl group, a chrysenyl group, apyridinyl group, a pyrazinyl group, a pyrimidinyl group, a pyridazinylgroup, a quinolinyl group, an isoquinolinyl group, a quinoxalinyl group,a quinazolinyl group, a carbazolyl group, a triazinyl group, abenzocarbazolyl group, and a dibenzocarbazolyl group, each substitutedwith at least one selected from a deuterium, —F, —Cl, —Br, —I, ahydroxyl group, a cyano group, a nitro group, an amino group, an amidinogroup, a hydrazine group, a hydrazone group, a carboxylic acid or a saltthereof, a sulfonic acid or a salt thereof, a phosphoric acid or a saltthereof, a C₁-C₂₀ alkyl group, a C₁-C₂₀ alkoxy group, a phenyl group anda naphthyl group; and

—Si(Q₃₁)(Q₃₂)(Q₃₃),

e1 may be an integer selected from 1 to 5, e2 may be an integer selectedfrom 1 to 7, e3 may be an integer selected from 1 to 3, e4 may be aninteger selected from 1 to 4, e5 may be an integer of 1 or 2, and * is abinding site to a neighboring atom.

In some embodiments, Ar₁ may be a group represented by one of Formulae6-1 to 6-24.

In Formulae 6-1 to 6-24, * is a binding site to a neighboring atom.

In Formulae 2-1 and 2-2, R₁ to R₁₂ and R₂₁ to R₃₂ may each independentlybe selected from or include, e.g., a binding site (to one of A₁, L₁, andA₂ in Formula 1), a hydrogen, a deuterium, —F, —Cl, —Br, —I, a hydroxylgroup, a cyano group, a nitro group, an amino group, an amidino group, ahydrazine group, a hydrazone group, a carboxylic acid or a salt thereof,a sulfonic acid or a salt thereof, a phosphoric acid or a salt thereof,a substituted or unsubstituted C₁-C₆₀ alkyl group, a substituted orunsubstituted C₂-C₆₀ alkenyl group, a substituted or unsubstitutedC₂-C₆₀ alkynyl group, a substituted or unsubstituted C₁-C₆₀ alkoxygroup, a substituted or unsubstituted C₃-C₁₀ cycloalkyl group, asubstituted or unsubstituted C₁-C₁₀ heterocycloalkyl group, asubstituted or unsubstituted C₃-C₁₀ cycloalkenyl group, a substituted orunsubstituted C₁-C₁₀ heterocycloalkenyl group, a substituted orunsubstituted C₆-C₆₀ aryl group, a substituted or unsubstituted C₆-C₆₀aryloxy group, a substituted or unsubstituted C₆-C₆₀ arylthio group, asubstituted or unsubstituted C₁-C₆₀ heteroaryl group, a substituted orunsubstituted monovalent non-aromatic condensed polycyclic group, asubstituted or unsubstituted monovalent non-aromatic condensedheteropolycyclic group, —Si(Q₁)(Q₂)(Q₃), —B(Q₄)(Q₅), and N(Q₆)(Q₇).

For example, at least one of R₁ to R₁₂ is a binding site to L₁ or A₁ inFormula 1, and at least one of R₂₁ to R₃₂ is a binding site to L₁ or A₁in Formula 1.

In one embodiment, R₁ to R₁₂ and R₂₁ to R₃₂ may each independently beselected from, e.g.,

a binding site to one of A₁, L₁, and A₂ in Formula 1;

a hydrogen, a deuterium, —F, —Cl, —Br, —I, a hydroxyl group, a cyanogroup, a nitro group, an amino group, an amidino group, a hydrazinegroup, a hydrazone group, a carboxylic acid or a salt thereof, asulfonic acid or a salt thereof, a phosphoric acid or a salt thereof, aC₁-C₂₀ alkyl group, and a C₁-C₂₀ alkoxy group;

a C₁-C₂₀ alkyl group and a C₁-C₂₀ alkoxy group, each substituted with atleast one selected from a deuterium, —F, —Cl, —Br, —I, a hydroxyl group,a cyano group, a nitro group, an amino group, an amidino group, ahydrazine group, a hydrazone group, a carboxylic acid or a salt thereof,a sulfonic acid or a salt thereof, a phosphoric acid or a salt thereof,a phenyl group, a naphthyl group, a pyridinyl group, and a pyrimidinylgroup;

a phenyl group, a naphthyl group, a fluorenyl group, a phenanthrenylgroup, an anthracenyl group, a fluoranthenyl group, a triphenylenylgroup, a pyrenyl group, a chrysenyl group, a pyrrolyl group, athiophenyl group, a furanyl group, an imidazolyl group, a pyrazolylgroup, a thiazolyl group, an isothiazolyl group, an oxazolyl group, anisoxazolyl group, a pyridinyl group, a pyrazinyl group, a pyrimidinylgroup, a pyridazinyl group, an isoindolyl group, an indolyl group, anindazolyl group, a purinyl group, a quinolinyl group, an isoquinolinylgroup, a benzoquinolinyl group, a quinoxalinyl group, a quinazolinylgroup, a cinnolinyl group, a carbazolyl group, a phenanthrolinyl group,a benzoimidazolyl group, a benzofuranyl group, a benzothiophenyl group,an isobenzothiazolyl group, a benzoxazolyl group, an isobenzoxazolylgroup, a triazolyl group, a tetrazolyl group, an oxadiazolyl group, atriazinyl group, a dibenzofuranyl group, a dibenzothiophenyl group, abenzocarbazolyl group, a dibenzocarbazolyl group, an imidazopyridinylgroup, and an imidazopyrimidinyl group;

a phenyl group, a naphthyl group, a fluorenyl group, a phenanthrenylgroup, an anthracenyl group, a fluoranthenyl group, a triphenylenylgroup, a pyrenyl group, a chrysenyl group, a pyrrolyl group, athiophenyl group, a furanyl group, an imidazolyl group, a pyrazolylgroup, a thiazolyl group, an isothiazolyl group, an oxazolyl group, anisoxazolyl group, a pyridinyl group, a pyrazinyl group, a pyrimidinylgroup, a pyridazinyl group, an isoindolyl group, an indolyl group, anindazolyl group, a purinyl group, a quinolinyl group, an isoquinolinylgroup, a benzoquinolinyl group, a quinoxalinyl group, a quinazolinylgroup, a cinnolinyl group, a carbazolyl group, a phenanthrolinyl group,a benzoimidazolyl group, a benzofuranyl group, a benzothiophenyl group,an isobenzothiazolyl group, a benzoxazolyl group, an isobenzoxazolylgroup, a triazolyl group, a tetrazolyl group, an oxadiazolyl group, atriazinyl group, a dibenzofuranyl group, a dibenzothiophenyl group, abenzocarbazolyl group, a dibenzocarbazolyl group, an imidazopyridinylgroup, and an imidazopyrimidinyl group, each substituted with at leastone selected from a deuterium, —F, —Cl, —Br, —I, a hydroxyl group, acyano group, a nitro group, an amino group, an amidino group, ahydrazine group, a hydrazone group, a carboxylic acid or a salt thereof,a sulfonic acid or a salt thereof, a phosphoric acid or a salt thereof,a C₁-C₂₀ alkyl group, a C₁-C₂₀ alkoxy group, a phenyl group, a naphthylgroup, a fluorenyl group, a phenanthrenyl group, an anthracenyl group, afluoranthenyl group, a triphenylenyl group, a pyrenyl group, a chrysenylgroup, a pyrrolyl group, a thiophenyl group, a furanyl group, animidazolyl group, a pyrazolyl group, a thiazolyl group, an isothiazolylgroup, an oxazolyl group, an isoxazolyl group, a pyridinyl group, apyrazinyl group, a pyrimidinyl group, a pyridazinyl group, an isoindolylgroup, an indolyl group, an indazolyl group, a purinyl group, aquinolinyl group, an isoquinolinyl group, a benzoquinolinyl group, aquinoxalinyl group, a quinazolinyl group, a cinnolinyl group, acarbazolyl group, a phenanthrolinyl group, a benzoimidazolyl group, abenzofuranyl group, a benzothiophenyl group, an isobenzothiazolyl group,a benzoxazolyl group, an isobenzoxazolyl group, a triazolyl group, atetrazolyl group, an oxadiazolyl group, a triazinyl group, adibenzofuranyl group, a dibenzothiophenyl group, a benzocarbazolylgroup, a dibenzocarbazolyl group, an imidazopyridinyl group, animidazopyrimidinyl group, and —Si(Q₃₁)(Q₃₂)(Q₃₃); and

—Si(Q₁)(Q₂)(Q₃),

where one of R₁ to R₁₂ is a binding site to L₁ or A₁ in Formula 1, andone of R₂₁ to R₃₂ is a binding site to L₁ or A₁ in Formula 1.

In one embodiment, R₁ to R₁₂ and R₂₁ to R₃₂ may each independently beselected from, e.g.,

a binding site to one of A₁, L₁, and A₂ in Formula 1,

a hydrogen, —F, a cyano group, a nitro group, a methyl group, an ethylgroup, a propyl group, an n-butyl group, an iso-butyl group, a sec-butylgroup, a tert-butyl group, an n-pentyl group, an iso-pentyl group, asec-pentyl group, a tert-pentyl group, an n-hexyl group, an iso-hexylgroup, a sec-hexyl group, a tert-hexyl group, an n-heptyl group, aniso-heptyl group, a sec-heptyl group, a tert-heptyl group, an n-octylgroup, an iso-octyl group, a sec-octyl group, a tert-octyl group, ann-nonyl group, an iso-nonyl group, a sec-nonyl group, a tert-nonylgroup, an n-decanyl group, an isodecanyl group, a sec-decanyl group, atert-decanyl group, a methoxy group, an ethoxy group, a propoxy group, abutoxy group, a pentoxy group, a phenyl group, a naphthyl group, apyridinyl group, a pyrimidinyl group, and a triazinyl group;

a methyl group, an ethyl group, a propyl group, an n-butyl group, aniso-butyl group, a sec-butyl group, a tert-butyl group, an n-pentylgroup, an iso-pentyl group, a sec-pentyl group, a tert-pentyl group, ann-hexyl group, an iso-hexyl group, a sec-hexyl group, a tert-hexylgroup, an n-heptyl group, an iso-heptyl group, a sec-heptyl group, atert-heptyl group, an n-octyl group, an iso-octyl group, a sec-octylgroup, a tert-octyl group, an n-nonyl group, an iso-nonyl group, asec-nonyl group, a tert-nonyl group, an n-decanyl group, an isodecanylgroup, a sec-decanyl group, a tert-decanyl group, a methoxy group, anethoxy group, a propoxy group, a butoxy group, a pentoxy group, a phenylgroup, a naphthyl group, a pyridinyl group, a pyrimidinyl group, and atriazinyl group, each substituted with at least one selected from —F, acyano group, a nitro group, a phenyl group, a naphthyl group, apyridinyl group, a pyrimidinyl group, a triazinyl group, and—Si(Q₃₁)(Q₃₂)(Q₃₃); and

—Si(Q₁)(Q₂)(Q₃), and

one of R₁ to R₁₂ is a binding site to L₁ or A₂ in Formula 1, and one ofR₂₁ to R₃₂ is a binding site to L₁ or A₁ in Formula 1.

In one embodiment, the condensed cyclic compound may be, e.g.,represented by one of the following Formulae 1A to 1L.

In Formulae 1A to 1L,

L₁, L₂, b1, b2, Ar₁, R₁ to R₁₂, and R₂₁ to R₃₂ may be the same asdescribed above with respect to Formulae 1, 2-1, and/or 2-2.

In one embodiment, in Formulae 1A to 1L, L₁ and L₂ may eachindependently be a group represented by one of Formula 4-1 to 4-20, andb1 and b2 may each independently be selected from 0, 1, and 2.

In Formulae 4-1 to 4-20, * and *′ are a binding site to a neighboringatom.

In some embodiments, in Formulae 1A to 1L, L₁ and L₂ may eachindependently be a group represented by one of Formulae 4-1 to 4-3, andb1 and b2 may each independently be 0 or 1.

In one embodiment, in Formulae 1A to 1L, Ar1 may be a group representedby one of Formulae 6-1 to 6-19, and R₁ to R₁₂ and R₂₁ to R₃₂ may eachindependently be a group represented by one of Formulae 7-1 to 7-6.

In Formulae 6-1 to 6-19 and 7-1 to 7-6, * is a binding site to aneighboring atom.

In an implementation, the compound represented by Formula 1 may be oneof the following Compounds 1 to 75:

In the condensed cyclic compound represented by Formula 1, A₁ may be agroup represented by Formula 2-1, and A₂ may be a group represented byFormula 2-2. For example, the condensed cyclic compound represented byFormula 1 may include both the group represented by Formula 2-1 and thegroup represented by Formula 2-2. In this regard, the electricalstability of the condensed cyclic compound represented by Formula 1 mayincrease. Thus, an electrical device including the condensed cycliccompound, e.g., an organic light-emitting device, may have an increasedlifespan.

In an implementation, in Formula 2-1, L₂ may not be “a substituted orunsubstituted triphenylenylene group” and/or Ar₁ may not be “asubstituted or unsubstituted triphenylenyl group”. A number of R₁ to R₁₂in Formula 2-1 that are a binding site to L₁ or A₂ in Formula 1 may beequal to a1. For example, if a1 is 1, one of R₁ to R₁₂ is a bindingsite, if a1 is 2, two of R₁ to R₁₂ is a binding site, etc. In thisregard, the condensed cyclic compound represented by Formula 1 may havehigh triplet energy. The condensed cyclic compound may be synthesized byusing a suitable organic synthesis method. The synthesis method of thecondensed cyclic compound may be recognized by referring to the Examplesin the specification.

At least one of the condensed cyclic compounds represented by Formula 1may be included between a pair of electrodes of an organiclight-emitting device. For example, the condensed cyclic compound may beincluded in an emission layer. For example, an organic light-emittingdevice may include a first electrode, a second electrode facing thefirst electrode, and an organic layer between the first electrode andthe second electrode, the organic layer including an emission layer. Theemission layer of the organic layer may include at least one condensedcyclic compound represented by Formula 1.

As used herein, the expression the “(organic layer) includes at leastone condensed cyclic compound” may be construed as meaning the “(organiclayer) may include one condensed cyclic compound in a range of Formula 1or two different condensed cyclic compounds in a range of Formula 1”.

In some embodiments, the organic layer may include only Compound 1 asthe condensed cyclic compound. Here, Compound 1 may be included in theemission layer of the organic light-emitting device.

The organic layer may include, e.g., i) a hole transport region that isbetween the first electrode (an anode) and the emission layer and thatincludes at least one of a hole injection layer, a hole transport layer,a buffer layer, and an electron blocking layer and ii) an electrontransport region that is between the emission layer and the secondelectrode (a cathode) and that includes at least one of a hole blockinglayer, an electron transport layer, and an electron injection layer. Theemission layer may include the condensed cyclic compound represented byFormula 1.

As used herein, the term the “organic layer” refers to a single and/or aplurality of layers disposed between the first electrode and the secondelectrode in an organic light-emitting device. A material included inthe “organic layer” is not limited to an organic material.

FIG. 1 illustrates a schematic view of an organic light-emitting device10 according to an embodiment. The organic light-emitting device 10 mayinclude a first electrode 110, an organic layer 150, and a secondelectrode 190.

Hereinafter, a structure and a method of manufacturing an organiclight-emitting device according to an embodiment will be described withreference to FIG. 1.

Referring to FIG. 1, a substrate may be additionally disposed under thefirst electrode 110 or on the second electrode 190. The substrate may bea glass substrate or transparent plastic substrate, each with excellentmechanical strength, thermal stability, transparency, surfacesmoothness, ease of handling, and water resistance.

The first electrode 110 may be formed by depositing or sputtering amaterial for forming the first electrode 110 on the substrate. When thefirst electrode 110 is an anode, the material for the first electrode110 may be selected from materials with a high work function tofacilitate hole injection. The first electrode 110 may be a reflectiveelectrode, a semi-transmissive electrode, or a transmissive electrode.The material for the first electrode 110 may be a transparent and highlyconductive material, and examples of such a material may include indiumtin oxide (ITO), indium zinc oxide (IZO), tin oxide (SnO₂), and zincoxide (ZnO). When the first electrode 110 is a semi-transmissiveelectrode or a reflective electrode, as a material for forming the firstelectrode, at least one selected from magnesium (Mg), aluminum (Al),aluminum-lithium (Al—Li), calcium (Ca), magnesium-indium (Mg—In), andmagnesium-silver (Mg—Ag) may be used.

The first electrode 110 may have a single-layer structure, or amulti-layer structure including a plurality of layers. For example, thefirst electrode 110 may have a triple-layer structure of ITO/Ag/ITO.

The organic layer 150 may be disposed on the first electrode 110. Theorganic layer 150 may include an emission layer.

The organic layer 150 may further include a hole transport regionbetween the first electrode 110 and the emission layer, and an electrontransport region between the emission layer and the second electrode190.

The hole transport region may include at least one of a hole injectionlayer (HIL), a hole transport layer (HTL), a buffer layer, and anelectron blocking layer (EBL). The electron transport region may includeat least one of a hole blocking layer (HBL), an electron transport layer(ETL), and an electron injection layer (EIL).

The hole transport region may have a single-layered structure formed ofa single material, a single-layered structure formed of a plurality ofdifferent materials, or a multi-layered structure having a plurality oflayers formed of a plurality of different materials.

For example, the hole transport region may have a single-layeredstructure formed of a plurality of different materials or a structure ofhole injection layer/hole transport layer, a structure of hole injectionlayer/hole transport layer/buffer layer, a structure of hole injectionlayer/buffer layer, a structure of hole transport layer/buffer layer, ora structure of hole injection layer/hole transport layer/electronblocking layer, each structure sequentially stacked on the firstelectrode 110.

When the hole transport region includes a hole injection layer, the holeinjection layer may be formed on the first electrode 110 by usingvarious methods, e.g., vacuum deposition, spin coating, casting, aLangmuir-Blodgett (LB) method, inkjet printing, laser printing, orlaser-induced thermal imaging (LITI).

When a hole injection layer is formed by vacuum deposition, e.g., thevacuum deposition may be performed at a deposition temperature in arange of about 100° C. to about 500° C., at a vacuum degree in a rangeof about 10⁻⁸ torr to about 10⁻³ torr, and/or at a deposition rate in arange of about 0.01 Å/sec to about 100 Å/sec, though the conditions mayvary depending on a compound for a hole injection material and astructure of a desired hole injection layer.

When a hole injection layer is formed by spin coating, the spin coatingmay be performed at a coating rate of about 2,000 rpm to about 5,000 rpmand/or at a temperature of about 80° C. to about 200° C. by taking intoaccount a compound for a hole injection layer to be deposited and thestructure of a hole injection layer to be formed.

When the hole transport region includes a hole transport layer, the holetransport layer may be formed on the first electrode 110 or the holeinjection layer by using various methods, e.g., vacuum deposition, spincoating, casting, LB method, inkjet printing, laser printing, or LITI.When the hole transport layer is formed by vacuum deposition or spincoating, conditions for vacuum deposition and coating may be similar tothe above-described vacuum deposition and coating conditions for formingthe hole injection layer. The hole transport region may include at leastone selected from m-MTDATA, TDATA, 2-TNATA, NPB, β-NPB, TPD, aspiro-TPD, a spiro-NPB, α-NPB, TAPC, HMTPD,4,4′,4″-tris(N-carbazolyl)triphenylamine (TCTA),polyaniline/dodecylbenzenesulfonic acid (Pani/DBSA),poly(3,4-ethylenedioxythiophene)/poly(4-styrenesulfonate) (PEDOT/PSS),polyaniline/camphor sulfonicacid (Pani/CSA),(polyaniline)/poly(4-styrenesulfonate) (PANI/PSS), a compoundrepresented by Formula 201 below, and a compound represented by Formula202 below.

In Formulae 201 and 202,

L₂₀₁ to L₂₀₅ may each independently be the same as defined in connectionwith L₁ to L₃;

xa1 to xa4 may each independently be selected from 0, 1, 2, and 3;

xa5 may be selected from 1, 2, 3, 4, and 5;

R₂₀₁ to R₂₀₄ may each independently be selected from a substituted orunsubstituted C₃-C₁₀ cycloalkyl group, a substituted or unsubstitutedC₁-C₁₀ heterocycloalkyl group, a substituted or unsubstituted C₃-C₁₀cycloalkenyl group, a substituted or unsubstituted C₁-C₁₀heterocycloalkenyl group, a substituted or unsubstituted C₆-C₆₀ arylgroup, a substituted or unsubstituted C₆-C₆₀ aryloxy group, asubstituted or unsubstituted C₆-C₆₀ arylthio group, a substituted orunsubstituted C₁-C₆₀ heteroaryl group, a substituted or unsubstitutedmonovalent non-aromatic condensed polycyclic group, and a substituted orunsubstituted monovalent non-aromatic condensed heteropolycyclic group.

For example, in Formulae 201 and 202,

L₂₀₁ to L₂₀₅ may each independently be selected from:

a phenylene group, a naphthylene group, a fluorenylene group, aspiro-fluorenylene group, a benzofluorene group, a dibenzofluorenegroup, a phenanthrenylene group, an anthracenylene group, a pyrenylenegroup, a chrysenylene group, a pyridinylene group, a pyrazinylene group,a pyrimidinylene group, a pyridazinylene group, a quinolinylene group,an isoquinolinylene group, a quinoxalinylene group, a quinazolinylenegroup, a carbazolylene group, and a triazinylene group; and

a phenylene group, a naphthylene group, a fluorenylene group, aspiro-fluorenylene group, a benzofluorenylene group, adibenzofluorenylene group, a phenanthrenylene group, an anthracenylenegroup, a pyrenylene group, a chrysenylene group, a pyridinylene group, apyrazinylene group, a pyrimidinylene group, a pyridazinylene group, aquinolinylene group, an isoquinolinylene group, a quinoxalinylene group,a quinazolinylene group, a carbazolylene group, and a triazinylenegroup, each substituted with at least one selected from a deuterium, —F,—Cl, —Br, —I, a hydroxyl group, a cyano group, a nitro group, an aminogroup, an amidino group, a hydrazine group, a hydrazone group, acarboxylic acid or a salt thereof, a sulfonic acid or a salt thereof, aphosphoric acid or a salt thereof, a C₁-C₂₀ alkyl group, a C₁-C₂₀ alkoxygroup, a phenyl group, a naphthyl group, a fluorenyl group, aspiro-fluorenyl group, a benzofluorenyl group, a dibenzofluorenyl group,a phenanthrenyl group, an anthracenyl group, a pyrenyl group, achrysenyl group, a pyridinyl group, a pyrazinyl group, a pyrimidinylgroup, a pyridazinyl group, an isoindolyl group, a quinolinyl group, anisoquinolinyl group, a quinoxalinyl group, a quinazolinyl group, acarbazolyl group, and a triazinyl group;

xa1 to xa4 may each independently be 0, 1, or 2;

xa5 may be 1, 2, or 3;

R₂₀₁ to R₂₀₄ may each independently be selected from:

a phenyl group, a naphthyl group, a fluorenyl group, a spiro-fluorenylgroup, a benzofluorenyl group, a dibenzofluorenyl group, a phenanthrenylgroup, an anthracenyl group, a pyrenyl group, a chrysenyl group, apyridinyl group, a pyrazinyl group, a pyrimidinyl group, a pyridazinylgroup, a quinolinyl group, an isoquinolinyl group, a quinoxalinyl group,a quinazolinyl group, a carbazolyl group, and a triazinyl group; and

a phenyl group, a naphthyl group, a fluorenyl group, a spiro-fluorenylgroup, a benzofluorenyl group, a dibenzofluorenyl group, a phenanthrenylgroup, an anthracenyl group, a pyrenyl group, a chrysenyl group, apyridinyl group, a pyrazinyl group, a pyrimidinyl group, a pyridazinylgroup, a quinolinyl group, an isoquinolinyl group, a quinoxalinyl group,a quinazolinyl group, a carbazolyl group, and a triazinyl group, eachsubstituted with at least one selected from a deuterium, —F, —Cl, —Br,—I, a hydroxyl group, a cyano group, a nitro group, an amino group, anamidino group, a hydrazine group, a hydrazone group, a carboxylic acidor a salt thereof, a sulfonic acid or a salt thereof, a phosphoric acidor a salt thereof, a C₁-C₂₀ alkyl group, a C₁-C₂₀ alkoxy group, a phenylgroup, a naphthyl group, an azulenyl group, a fluorenyl group, aspiro-fluorenyl group, a benzofluorenyl group, a dibenzofluorenyl group,a phenanthrenyl group, an anthracenyl group, a pyrenyl group, achrysenyl group, a pyridinyl group, a pyrazinyl group, a pyrimidinylgroup, a pyridazinyl group, a quinolinyl group, an isoquinolinyl group,a quinoxalinyl group, a quinazolinyl group, a carbazolyl group, and atriazinyl group, but embodiments are not limited thereto.

The compound represented by Formula 201 may be represented by Formula201A:

For example, the compound represented by Formula 201 may be representedby Formula 201A-1.

The compound represented by Formula 202 may be represented by Formula202A.

In Formula 201A, 201A-1, and 202A, L₂₀₁ to L₂₀₃, xa1 to xa3, xa5, andR₂₀₂ to R₂₀₄ may be the same as disclosed in the present specification,R₂₁₁ and R₂₁₂ may each independently be the same as defined inconnection with R_(203,) and R₂₁₃ to R₂₁₆ may each independently beselected from a hydrogen, a deuterium, —F, —Cl, —Br, —I, a hydroxylgroup, a cyano group, a nitro group, an amino group, an amidino group, ahydrazine group, a hydrazone group, a carboxylic acid or a salt thereof,a sulfonic acid or a salt thereof, a phosphoric acid or a salt thereof,a C₁-C₆₀ alkyl group, a C₂-C₆₀ alkenyl group, a C₂-C₆₀ alkynyl group, aC₁-C₆₀) alkoxy group, a C₃-C₁₀ cycloalkyl group, a C₁-C₁₀heterocycloalkyl group, a C₃-C₁₀ cycloalkenyl group, a C₁-C₁₀heterocycloalkenyl group, a C₆-C₆₀ aryl group, a C₆-C₆₀ aryloxy group,C₆-C₆₀ arylthio group, a C₁-C₆₀ heteroaryl group, a monovalentnon-aromatic condensed polycyclic group, and a monovalent non-aromaticcondensed heteropolycyclic group.

For example, in Formulae 201A, 201A-1, and 202A,

L₂₀₁ to L₂₀₃ may each independently be selected from:

a phenylene group, a naphthylene group, a fluorenylene group, aspiro-fluorenylene group, a benzofluorenylene group, adibenzofluorenylene group, a phenanthrenylene group, an anthracenylenegroup, a pyrenylene group, a chrysenylene group, a pyridinylene group, apyrazinylene group, a pyrimidinylene group, a pyridazinylene group, aquinolinylene group, an isoquinolinylene group, a quinoxalinylene group,a quinazolinylene group, a carbazolylene group, and a triazinylenegroup; and

a phenylene group, a naphthylene group, a fluorenylene group, aspiro-fluorenylene group, a benzofluorenylene group, adibenzofluorenylene group, a phenanthrenylene group, an anthracenylenegroup, a pyrenylene group, a chrysenylene group, a pyridinylene group, apyrazinylene group, a pyrimidinylene group, a pyridazinylene group, aquinolinylene group, an isoquinolinylene group, a quinoxalinylene group,a quinazolinylene group, a carbazolylene group, and a triazinylenegroup, each substituted with at least one selected from a deuterium, —F,—Cl, —Br, —I, a hydroxyl group, a cyano group, a nitro group, an aminogroup, an amidino group, a hydrazine group, a hydrazone group, acarboxylic acid or a salt thereof, a sulfonic acid or a salt thereof, aphosphoric acid or a salt thereof, a C₁-C₂₀ alkyl group, a C₁-C₂₀ alkoxygroup, a phenyl group, a naphthyl group, a fluorenyl group, aspiro-fluorenyl group, a benzofluorenyl group, a dibenzofluorenyl group,a phenanthrenyl group, an anthracenyl group, a pyrenyl group, achrysenyl group, a pyridinyl group, a pyrazinyl group, a pyrimidinylgroup, a pyridazinyl group, a quinolinyl group, an isoquinolinyl group,a quinoxalinyl group, a quinazolinyl group, a carbazolyl group, and atriazinyl group;

xa1 to xa3 may each independently be 0 or 1;

R₂₀₃, R₂₀₄, R₂₁₁, and R₂₁₂ may each independently be selected from:

a phenyl group, a naphthyl group, a fluorenyl group, a spiro-fluorenylgroup, a benzofluorenyl group, a dibenzofluorenyl group, a phenanthrenylgroup, an anthracenyl group, a pyrenyl group, a chrysenyl group, apyridinyl group, a pyrazinyl group, a pyrimidinyl group, a pyridazinylgroup, a quinolinyl group, an isoquinolinyl group, a quinoxalinyl group,a quinazolinyl group, a carbazolyl group, and a triazinyl group; and

a phenyl group, a naphthyl group, a fluorenyl group, a spiro-fluorenylgroup, a benzofluorenyl group, a dibenzofluorenyl group, a phenanthrenylgroup, an anthracenyl group, a pyrenyl group, a chrysenyl group, aphenanthrenyl group, an anthracenyl group, a pyrenyl group, a chrysenylgroup, a pyridinyl group, a pyrazinyl group, a pyrimidinyl group, apyridazinyl group, a quinolinyl group, an isoquinolinyl group, aquinoxalinyl group, a quinazolinyl group, a carbazolyl group, and atriazinyl group, each substituted with at least one selected from adeuterium, —F, —Cl, —Br, —I, a hydroxyl group, a cyano group, a nitrogroup, an amino group, an amidino group, a hydrazine group, a hydrazonegroup, a carboxylic acid or a salt thereof, a sulfonic acid or a saltthereof, a phosphoric acid or a salt thereof, a C₁-C₂₀ alkyl group, aC₁-C₂₀ alkoxy group, a phenyl group, a naphthyl group, a fluorenylgroup, a spiro-fluorenyl group, a benzofluorenyl group, adibenzofluorenyl group, a phenanthrenyl group, an anthracenyl group, apyrenyl group, a chrysenyl group, a pyridinyl group, a pyrazinyl group,a pyrimidinyl group, a pyridazinyl group, a quinolinyl group, anisoquinolinyl group, a quinoxalinyl group, a quinazolinyl group, acarbazolyl group, and a triazinyl group;

R₂₁₃ and R₂₁₄ may each independently be selected from:

a C₁-C₂₀ alkyl group and a C₁-C₂₀ alkoxy group;

a C₁-C₂₀ alkyl group and a C₁-C₂₀ alkoxy group, each substituted with atleast one selected from a deuterium, —F, —Cl, —Br, —I, a hydroxyl group,a cyano group, a nitro group, an amino group, an amidino group, ahydrazine group, a hydrazone group, a carboxylic acid or a salt thereof,a sulfonic acid or a salt thereof, a phosphoric acid or a salt thereof,a phenyl group, a naphthyl group, a fluorenyl group, a spiro-fluorenylgroup, a benzofluorenyl group, a dibenzofluorenyl group, a phenanthrenylgroup, an anthracenyl group, a pyrenyl group, a chrysenyl group, apyridinyl group, a pyrazinyl group, a pyrimidinyl group, a pyridazinylgroup, a quinolinyl group, an isoquinolinyl group, a quinoxalinyl group,a quinazolinyl group, a carbazolyl group, and a triazinyl group;

a phenyl group, a naphthyl group, a fluorenyl group, a spiro-fluorenylgroup, a benzofluorenyl group, a dibenzofluorenyl group, a phenanthrenylgroup, an anthracenyl group, a pyrenyl group, a chrysenyl group, apyridinyl group, a pyrazinyl group, a pyrimidinyl group, a pyridazinylgroup, a quinolinyl group, an isoquinolinyl group, a quinoxalinyl group,a quinazolinyl group, a carbazolyl group, and a triazinyl group; and

a phenyl group, a naphthyl group, a fluorenyl group, a spiro-fluorenylgroup, a benzofluorenyl group, a dibenzofluorenyl group, a phenanthrenylgroup, an anthracenyl group, a pyrenyl group, a chrysenyl group, apyridinyl group, a pyrazinyl group, a pyrimidinyl group, a pyridazinylgroup, a quinolinyl group, an isoquinolinyl group, a quinoxalinyl group,a quinazolinyl group, a carbazolyl group, and a triazinyl group, eachsubstituted with at least one selected from a deuterium, —F, —Cl, —Br,—I, a hydroxyl group, a cyano group, a nitro group, an amino group, anamidino group, a hydrazine group, a hydrazone group, a carboxylic acidor a salt thereof, a sulfonic acid or a salt thereof, a phosphoric acidor a salt thereof, a C₁-C₂₀ alkyl group, a C₁-C₂₀ alkoxy group, a phenylgroup, a naphthyl group, a fluorenyl group, a spiro-fluorenyl group, abenzofluorenyl group, a dibenzofluorenyl group, a phenanthrenyl group,an anthracenyl group, a pyrenyl group, a chrysenyl group, a pyridinylgroup, a pyrazinyl group, a pyrimidinyl group, a pyridazinyl group, aquinolinyl group, an isoquinolinyl group, a quinoxalinyl group, aquinazolinyl group, a carbazolyl group, and a triazinyl group;

R₂₁₅ and R₂₁₆ may each independently be selected from:

a hydrogen, a deuterium, —F, —Cl, —Br, —I, a hydroxyl group, a cyanogroup, a nitro group, an amino group, an amidino group, a hydrazinegroup, a hydrazone group, a carboxylic acid or a salt thereof, asulfonic acid or a salt thereof, a phosphoric acid or a salt thereof, aC₁-C₂₀ alkyl group, and a C₁-C₂₀ alkoxy group;

a C₁-C₂₀ alkyl group and a C₁-C₂₀ alkoxy group, each substituted with atleast one selected from a deuterium, —F, —Cl, —Br, —I, a hydroxyl group,a cyano group, a nitro group, an amino group, an amidino group, ahydrazine group, a hydrazone group, a carboxylic acid or a salt thereof,a sulfonic acid or a salt thereof, a phosphoric acid or a salt thereof,a phenyl group, a naphthyl group, a fluorenyl group, a spiro-fluorenylgroup, a benzofluorenyl group, a dibenzofluorenyl group, a phenanthrenylgroup, an anthracenyl group, a pyrenyl group, a chrysenyl group, apyridinyl group, a pyrazinyl group, a pyrimidinyl group, a pyridazinylgroup, a quinolinyl group, an isoquinolinyl group, a quinoxalinyl group,a quinazolinyl group, a carbazolyl group, and a triazinyl group;

a phenyl group, a naphthyl group, a fluorenyl group, a spiro-fluorenylgroup, a benzofluorenyl group, a dibenzofluorenyl group, a phenanthrenylgroup, an anthracenyl group, a pyrenyl group, a chrysenyl group, apyridinyl group, a pyrazinyl group, a pyrimidinyl group, a pyridazinylgroup, a quinolinyl group, an isoquinolinyl group, a quinoxalinyl group,a quinazolinyl group, and a triazinyl group; and

a phenyl group, a naphthyl group, a fluorenyl group, a spiro-fluorenylgroup, a benzofluorenyl group, a dibenzofluorenyl group, a phenanthrenylgroup, an anthracenyl group, a pyrenyl group, a chrysenyl group, apyridinyl group, a pyrazinyl group, a pyrimidinyl group, a pyridazinylgroup, a quinolinyl group, an isoquinolinyl group, a quinoxalinyl group,a quinazolinyl group, a carbazolyl group, and a triazinyl group, eachsubstituted with at least one selected from a deuterium, —F, —Cl, —Br,—I, a hydroxyl group, a cyano group, a nitro group, an amino group, anamidino group, a hydrazine group, a hydrazone group, a carboxylic acidor a salt thereof, a sulfonic acid or a salt thereof, a phosphoric acidor a salt thereof, a C₁-C₂₀ alkyl group, a C₁-C₂₀ alkoxy group, a phenylgroup, a naphthyl group, a fluorenyl group, a spiro-fluorenyl group, abenzofluorenyl group, a dibenzofluorenyl group, a phenanthrenyl group,an anthracenyl group, a pyrenyl group, a chrysenyl group, a pyridinylgroup, a pyrazinyl group, a pyrimidinyl group, a pyridazinyl group, aquinolinyl group, an isoquinolinyl group, a quinoxalinyl group, aquinazolinyl group, a carbazolyl group, and a triazinyl group;

xa5 may be 1 or 2.

In an implementation, in Formulae 201A and 201A-1, R₂₁₃ and R₂₁₄ may belinked to each other and form a saturated or unsaturated ring.

The compound represented by Formula 201 and the compound represented byFormula 202 may include, e.g., one of Compounds HT1 to HT20 below.

A thickness of the hole transport region may be in a range of about 100Å to about 10,000 Å, e.g., about 100 Å to about 1000 Å. When the holetransport region includes both a hole injection layer and a holetransport layer, a thickness of the hole injection layer may be in arange of about 100 Å to about 10,000 Å, e.g., about 100 Å to about 1,000Å, and a thickness of the hole transport layer may be in a range ofabout 50 Å to about 2,000 Å, e.g., about 100 Å to about 1,500 Å. Whenthe thicknesses of the hole transport region, the hole injection layer,and the hole transport layer are within these ranges, satisfactory holetransporting characteristics may be obtained without a substantialincrease in driving voltage.

The hole transport region may further include, in addition to thesematerials, a charge-generation material for the improvement ofconductive properties. The charge-generation material may behomogeneously or non-homogeneously dispersed in the hole transportregion.

The charge-generation material may be, e.g., a p-dopant. The p-dopantmay include one of a quinone derivative, a metal oxide, and a cyanogroup-containing compound. Examples of the p-dopant may include aquinone derivative, such as tetracyanoquinonedimethane (TCNQ) or2,3,5,6-tetrafluoro-tetracyano-1,4-benzoquinonedimethane (F4-TCNQ); ametal oxide, such as a tungsten oxide or a molybdenum oxide; andCompound HT-D1 below.

The hole transport region may further include at least one of a bufferlayer and an electron blocking layer, in addition to the hole injectionlayer and the hole transport layer. The buffer layer may compensate foran optical resonance distance according to a wavelength of light emittedfrom the emission layer, and the light-emission efficiency of a formedorganic light-emitting device may be improved. A material included inthe buffer layer may be a material included in the hole transportregion. The electron blocking layer may help prevent injection ofelectrons from the electron transport region.

An emission layer may be formed on the first electrode 110 or the holetransport region by using various methods, e.g., vacuum deposition, spincoating, casting, LB method, inkjet printing, laser printing, or LITI.When the emission layer is formed by vacuum deposition or spin coating,deposition and coating conditions for the emission layer may bedetermined by referring to the deposition and coating conditions for thehole injection layer.

When the organic light-emitting device 10 is a full-color organiclight-emitting device, the emission layer may be patterned into a redemission layer, a green emission layer, or a blue emission layer,according to a sub-pixel. In an implementation, the emission layer mayhave a stacked structure of a red emission layer, a green emissionlayer, and a blue emission layer, or may include a red-light emissionmaterial, a green-light emission material, and a blue-light emissionmaterial, which are mixed with each other in a single layer, to emitwhite light.

The emission layer may include the condensed cyclic compound representedby Formula 1.

The emission layer may include a host and a dopant. In animplementation, the host may include the condensed cyclic compoundrepresented by Formula 1.

The dopant may include, e.g., at least one of a fluorescent dopant and aphosphorescent dopant.

The phosphorescent dopant may include, e.g., an organometallic complexrepresented by Formula 401 below.

In Formula 401,

M may be selected from, e.g., iridium (Ir), platinum (Pt), osmium (Os),titanium (Ti), zirconium (Zr), hafnium (Hf), europium (Eu), terbium(Tb), and thulium (Tm);

X₄₀₁ to X₄₀₄ may each independently be, e.g., nitrogen or carbon;

rings A₄₀₁ and A₄₀₂ may each independently be selected from or include,e.g., a substituted or unsubstituted benzene, a substituted orunsubstituted naphthalene, a substituted or unsubstituted fluorene, asubstituted or unsubstituted spiro-fluorene, a substituted orunsubstituted indene, a substituted or unsubstituted pyrrole, asubstituted or unsubstituted thiophene, a substituted or unsubstitutedfuran, a substituted or unsubstituted imidazole, a substituted orunsubstituted pyrazole, a substituted or unsubstituted thiazole, asubstituted or unsubstituted isothiazole, a substituted or unsubstitutedoxazole, a substituted or unsubstituted isoxazole, a substituted orunsubstituted pyridine, a substituted or unsubstituted pyrazine, asubstituted or unsubstituted pyrimidine, a substituted or unsubstitutedpyridazine, a substituted or unsubstituted quinoline, a substituted orunsubstituted isoquinoline, a substituted or unsubstitutedbenzoquinoline, a substituted or unsubstituted quinoxaline, asubstituted or unsubstituted quinazoline, a substituted or unsubstitutedcarbazole, a substituted or unsubstituted benzoimidazole, a substitutedor unsubstituted benzofuran, a substituted or unsubstitutedbenzothiophene, a substituted or unsubstituted isobenzothiophene, asubstituted or unsubstituted benzoxazole, a substituted or unsubstitutedisobenzoxazole, a substituted or unsubstituted triazole, a substitutedor unsubstituted oxadiazole, a substituted or unsubstituted triazine, asubstituted or unsubstituted dibenzofuran, and a substituted orunsubstituted dibenzothiophene;

at least one substituent of the substituted benzene, substitutednaphthalene, substituted fluorene, substituted spiro-fluorene,substituted indene, substituted pyrrole, substituted thiophene,substituted furan, substituted imidazole, substituted pyrazole,substituted thiazole, substituted isothiazole, substituted oxazole,substituted isoxazole, substituted pyridine, substituted pyrazine,substituted pyrimidine, substituted pyridazine, substituted quinoline,substituted isoquinoline, substituted benzoquinoline, substitutedquinoxaline, substituted quinazoline, substituted carbazole, substitutedbenzoimidazole, substituted benzofuran, substituted benzothiophene,substituted isobenzothiophene, substituted benzoxazole, substitutedisobenzoxazole, substituted triazole, substituted oxadiazole,substituted triazine, substituted dibenzofuran, and substituteddibenzothiophene may be selected from, e.g.,

a deuterium, —F, —Cl, —Br, —I, a hydroxyl group, a cyano group, a nitrogroup, an amino group, an amidino group, a hydrazine group, a hydrazonegroup, a carboxylic acid or a salt thereof, a sulfonic acid or a saltthereof, a phosphoric acid or a salt thereof, a C₁-C₆₀ alkyl group, aC₂-C₆₀ alkenyl group, a C₂-C₆₀ alkynyl group, and a C₁-C₆₀ alkoxy group;

a C₁-C₆₀ alkyl group, a C₂-C₆₀ alkenyl group, a C₂-C₆₀ alkynyl group,and a C₁-C₆₀ alkoxy group, each substituted with at least one selectedfrom a deuterium, —F, —Cl, —Br, —I, a hydroxyl group, a cyano group, anitro group, an amino group, an amidino group, a hydrazine group, ahydrazone group, a carboxylic acid or a salt thereof, a sulfonic acid ora salt thereof, a phosphoric acid or a salt thereof, a C₃-C₁₀ cycloalkylgroup, a C₁-C₁₀ heterocycloalkyl group, a C₃-C₁₀ cycloalkenyl group, aC₁-C₁₀ heterocycloalkenyl group, a C₆-C₆₀ aryl group, a C₆-C₆₀ aryloxygroup, a C₆-C₆₀ arylthio group, a C₁-C₆₀ heteroaryl group, a monovalentnon-aromatic condensed polycyclic group, a monovalent non-aromaticcondensed heteropolycyclic group, —N(Q₄₀₁)(Q₄₀₂), —Si(Q₄₀₃)(Q₄₀₄)(Q₄₀₅),and —B(Q₄₀₆)(Q₄₀₇);

a C₃-C₁₀ cycloalkyl group, a C₁-C₁₀ heterocycloalkyl group, a C₃-C₁₀cycloalkenyl group, a C₁-C₁₀ heterocycloalkenyl group, a C₆-C₆₀ arylgroup, a C₆-C₆₀ aryloxy group, a C₆-C₆₀ arylthio group, a C₁-C₆₀heteroaryl group, a monovalent non-aromatic condensed polycyclic group,and a monovalent non-aromatic condensed heteropolycyclic group;

a C₃-C₁₀ cycloalkyl group, a C₁-C₁₀ heterocycloalkyl group, a C₃-C₁₀cycloalkenyl group, a C₁-C₁₀ heterocycloalkenyl group, a C₆-C₆₀ arylgroup, a C₆-C₆₀ aryloxy group, a C₆-C₆₀ arylthio group, a C₁-C₆₀heteroaryl group, a monovalent non-aromatic condensed polycyclic group,and a monovalent non-aromatic condensed heteropolycyclic group, eachsubstituted with at least one selected from a deuterium, —F, —Cl, —Br,—I, a hydroxyl group, a cyano group, a nitro group, an amino group, anamidino group, a hydrazine group, a hydrazone group, a carboxylic acidor a salt thereof, a sulfonic acid or a salt thereof, a phosphoric acidor a salt thereof, a C₁-C₆₀ alkyl group, a C₂-C₆₀ alkenyl group, aC₂-C₆₀ alkynyl group, a C₁-C₆₀ alkoxy group, a C₃-C₁₀ cycloalkyl group,a C₁-C₁₀ heterocycloalkyl group, a C₃-C₁₀ cycloalkenyl group, a C₁-C₁₀heterocycloalkenyl group, a C₆-C₆₀ aryl group, a C₆-C₆₀ aryloxy group, aC₆-C₆₀ arylthio group, a C₁-C₆₀ heteroaryl group, a monovalentnon-aromatic condensed polycyclic group, a monovalent non-aromaticcondensed heteropolycyclic group, —N(Q₄₁₁)(Q₄₁₂), —Si(Q₄₁₃)(Q₄₁₄)(Q₄₁₅),and —B(Q₄₁₆)(Q₄₁₇); and

—N(Q₄₂₁)(Q₄₂₂), —Si(Q₄₂₃)(Q₄₂₄)(Q₄₂₅), and —B(Q₄₂₆)(Q₄₂₇);

L₄₀₁ may be an organic ligand;

xc1 may be 1, 2, or 3; and

xc2 may be 0, 1, 2, or 3.

The descriptions of Q₄₀₁ to Q₄₀₇, Q₄₁₁ to Q₄₁₇, and Q₄₂₁ to Q₄₂₇ may bethe same as defined in connection with Q₁ herein.

L₄₀₁ may be a monovalent, divalent, or trivalent organic ligand. In animplementation, L₄₀₁ may be selected from, e.g., a halogen ligand (forexample, Cl or F), a diketone ligand (for example, acetylacetonate,1,3-diphenyl-1,3-propandionate, 2,2,6,6-tetramethyl-3,5-heptandionate,or hexafluoroacetonate), a carboxylic acid ligand (for example,picolinate, dimethyl-3-pyrazolecarboxylate, or benzoate), a carbonmonoxide ligand, an isonitrile ligand, a cyano ligand, and a phosphorousligand (for example, phosphine, or phosphate).

In an implementation, in Formula 401, when ring A₄₀₁ has two or moresubstituents, the two or more substituents of ring A₄₀₁ may link to eachother and form a saturated or unsaturated ring.

In an implementation, in Formula 401, when ring A₄₀₂ has two or moresubstituents, the two or more substituents of ring A₄₀₂ may link to eachother and form a saturated or unsaturated ring.

In Formula 401, when xc1 is 2 or greater, a plurality of ligands inFormula 401 may be identical to or different from each other. In Formula401, when xc1 is 2 or greater, A₄₀₁ and A₄₀₂ may be respectively anddirectly linked to A₄₀₁ and A₄₀₂ of a different neighboring ligand ormay link to A₄₀₁ and A₄₀₂ of a different neighboring ligand via alinking group (e.g. a C₁-C₅ alkylene group, —N(R′)— (where, R′ is aC₁-C₁₀ alkyl group or a C₆-C₂₀ aryl group), or —C(═O)—) therebetween.

The phosphorescent dopant may include, e.g., at least one of thefollowing Compounds PD1 to PD74.

In some embodiments, the phosphorescent dopant may include PtOEP:

The fluorescent dopant may include, e.g., at least one selected fromDPAVBi, BDAVBi, TBPe, DCM, DCJTB, Coumarin 6, and C545T.

In some embodiments, the fluorescent dopant may include, e.g., acompound represented by Formula 501:

In Formula 501,

Ar₅₀₁ may be selected from:

a naphthalene, a heptalene, a fluorenene, a spiro-fluorene, abenzofluorene, a dibenzofluorene, a phenalene, a phenanthrene, ananthracene, a fluoranthene, a triphenylene, a pyrene, a chrysene, anaphthacene, a picene, a perylene, a pentaphene, and anindenoanthracene; and

a naphthalene, a heptalene, a fluorene, a spiro-fluorene, abenzofluorene, a dibenzofluorene, a phenalene, a phenanthrene, ananthracene, a fluoranthene, a triphenylene, a pyrene, a chrysene, anaphthacene, a picene, a perylene, a pentaphene, and anindenoanthracene, each substituted with at least one selected from adeuterium, —F, —Cl, —Br, —I, a hydroxyl group, a cyano group, a nitrogroup, an amino group, an amidino group, a hydrazine group, a hydrazonegroup, a carboxylic acid or a salt thereof, a sulfonic acid or a saltthereof, a phosphoric acid or a salt thereof, a C₁-C₆₀ alkyl group, aC₂-C₆₀ alkenyl group, a C₂-C₆₀ alkynyl group, a C₁-C₆₀ alkoxy group, aC₃-C₁₀ cycloalkyl group, a C₁-C₁₀ heterocycloalkyl group, a C₃-C₁₀cycloalkenyl group, a C₁-C₁₀ heterocycloalkenyl group, a C₆-C₆₀ arylgroup, a C₆-C₆₀ aryloxy group, a C₆-C₆₀ arylthio group, a C₁-C₆₀heteroaryl group, a monovalent non-aromatic condensed polycyclic group,a monovalent non-aromatic condensed heteropolycyclic group, and—Si(Q₅₀₁)(Q₅₀₂)(Q₅₀₃) (where, Q₅₀₁ to Q₅₀₃ are each independentlyselected from a hydrogen, a C₁-C₆₀ alkyl group, a C₂-C₆₀ alkenyl group,a C₆-C₆₀ aryl group, and a C₁-C₆₀ heteroaryl group);

descriptions of L₅₀₁ to L₅₀₃ may be the same as defined in connectionwith the description of L₂₀₁ herein;

R₅₀₁ and R₅₀₂ may each independently be selected from:

a phenyl group, a naphthyl group, a fluorenyl group, a spiro-fluorenylgroup, a benzofluorenyl group, a dibenzofluorenyl group, a phenanthrenylgroup, an anthracenyl group, a pyrenyl group, a chrysenyl group, apyridinyl group, a pyrazinyl group, a pyrimidinyl group, a pyridazinylgroup, a quinolinyl group, an isoquinolinyl group, a quinoxalinyl group,a quinazolinyl group, a carbazole group, a triazinyl group, adibenzofuranyl group, and a dibenzothiophenyl group; and

a phenyl group, a naphthyl group, a fluorenyl group, a spiro-fluorenylgroup, a benzofluorenyl group, a dibenzofluorenyl group, a phenanthrenylgroup, an anthracenyl group, a pyrenyl group, a chrysenyl group, apyridinyl group, a pyrazinyl group, a pyrimidinyl group, a pyridazinylgroup, a quinolinyl group, an isoquinolinyl group, a quinoxalinyl group,a quinazolinyl group, a carbazolyl group, a triazinyl group, adibenzofuranyl group, and a dibenzothiophenyl group, each substitutedwith at least one selected from a deuterium, —F, —Cl, —Br, —I, ahydroxyl group, a cyano group, a nitro group, an amino group, an amidinogroup, a hydrazine group, a hydrazone group, a carboxylic acid or a saltthereof, a sulfonic acid or a salt thereof, a phosphoric acid or a saltthereof, a C₁-C₂₀ alkyl group, a C₁-C₂₀ alkoxy group, a phenyl group, anaphthyl group, a fluorenyl group, a spiro-fluorenyl group, abenzofluorenyl group, a dibenzofluorenyl group, a phenanthrenyl group,an anthracenyl group, a pyrenyl group, a chrysenyl group, a pyridinylgroup, a pyrazinyl group, a pyrimidinyl group, a pyridazinyl group, aquinolinyl group, an isoquinolinyl group, a quinoxalinyl group, aquinazolinyl group, a carbazolyl group, a triazinyl group, adibenzofuranyl group, and a dibenzothiophenyl group;

xd1 to xd3 may each independently be selected from 0, 1, 2, and 3; and

xd4 may be selected from 1, 2, 3, and 4.

In the emission layer, the amount of the dopant may be generallyselected within a range of, e.g., about 0.01 parts to about 15 parts byweight, based on about 100 parts by weight of the host.

A thickness of the emission layer may be in a range of about 100 Å toabout 1,000 Å, e.g., about 200 Å to about 600 Å. When the thickness ofthe emission layer is within this range, excellent light-emissioncharacteristics may be obtained without a substantial increase indriving voltage.

Then, an electron transport region may be disposed on the emissionlayer.

The electron transport region may include at least one selected from ahole blocking layer, an electron transport layer, and an electroninjection layer.

For example, the electron transport region may have a structure ofelectron transport layer/electron injection layer or a structure of holeblocking layer/electron transport layer/electron injection layer,wherein layers of each structure are sequentially stacked from theemission layer in the stated order.

According to an embodiment, the organic layer 150 of the organiclight-emitting device may include an electron transport region betweenthe emission layer and the second electrode 190.

The electron transport region may include a hole blocking layer. Thehole blocking layer may be formed, when the emission layer includes aphosphorescent dopant, to help prevent diffusion of excitons or holesinto an electron transport layer.

When the electron transport region includes a hole blocking layer, thehole blocking layer may be formed on the emission layer by using variousmethods, e.g., vacuum deposition, spin coating, casting, an LB method,inkjet printing, laser printing, or LITI. When the hole blocking layeris formed by vacuum deposition or spin coating, deposition and coatingconditions for the hole blocking layer may be determined by referring tothe deposition and coating conditions for the hole injection layer.

The hole blocking layer may include, e.g., at least one selected fromBCP and Bphen.

A thickness of the hole blocking layer may be in a range of about 20 Åto about 1,000 Å, e.g., about 30 Å to about 300 Å. When the thickness ofthe hole blocking layer is within this range, excellent hole blockingcharacteristics may be obtained without a substantial increase indriving voltage.

The electron transport region may include an electron transport layer.The electron transport layer may be formed on the emission layer or thehole blocking layer by using various methods, e.g., vacuum deposition,spin coating, casting, an LB method, inkjet printing, laser printing, orLITI. When the electron transport layer is formed by using vacuumdeposition or spin coating, vacuum deposition and coating conditions forthe electron transport layer may be determined by referring to thevacuum deposition and coating conditions for the hole injection layer.

The electron transport layer may include, e.g., at least one selectedfrom BCP, Bphen, Alq₃, BAlq, TAZ, and NTAZ.

In some embodiments, the electron transport layer may include, e.g., atleast one compound selected from a compound represented by Formula 601and a compound represented by Formula 602 illustrated below.

Ar₆₀₁-[(L₆₀₁)_(xe1)-E₆₀₁]_(xe2)  Formula 601>

In Formula 601,

Ar₆₀₁ may be selected from:

a naphthalene, a heptalene, a fluorene, a spiro-fluorene, abenzofluorene, a dibenzofluorene, a phenalene, a phenanthrene, ananthracene, a fluoranthene, a triphenylene, a pyrene, a chrysene, anaphthacene, a picene, a perylene, a pentaphene, and anindenoanthracene;

a naphthalene, a heptalene, a fluorene, a spiro-fluorene, abenzofluorene, a dibenzofluorene, a phenalene, a phenanthrene, ananthracene, a fluoranthene, a triphenylene, a pyrene, a chrysene, anaphthacene, a picene, a perylene, a pentaphene, and anindenoanthracene, each substituted with at least one selected from adeuterium, —F, —Cl, —Br, —I, a hydroxyl group, a cyano group, a nitrogroup, an amino group, an amidino group, a hydrazine group, a hydrazonegroup, a carboxylic acid or a salt thereof, a sulfonic acid or a saltthereof, a phosphoric acid or a salt thereof, a C₁-C₆₀ alkyl group, aC₂-C₆₀ alkenyl group, a C₂-C₆₀ alkynyl group, a C₁-C₆₀ alkoxy group, aC₃-C₁₀ cycloalkyl group, a C₁-C₁₀ heterocycloalkyl group, a C₃-C₁₀cycloalkenyl group, a C₁-C₁₀ heterocycloalkenyl group, a C₆-C₆₀ arylgroup, a C₆-C₆₀ aryloxy group, a C₆-C₆₀ arylthio group, a C₁-C₆₀heteroaryl group, a monovalent non-aromatic condensed polycyclic group,a monovalent non-aromatic condensed heteropolycyclic group, and—Si(Q₃₀₁)(Q₃₀₂)(Q₃₀₃) (where, Q₃₀₁ to Q₃₀₃ may be each independentlyselected from a hydrogen, a C₁-C₆₀ alkyl group, a C₂-C₆₀ alkenyl group,a C₆-C₆₀ aryl group, and a C₁-C₆₀ heteroaryl group);

the descriptions for L₆₀₁ may be the same as defined in connection withL₂₀₁ herein;

E₆₀₁ may be selected from:

a pyrrolyl group, a thiophenyl group, a furanyl group, an imidazolylgroup, a pyrazolyl group, a thiazolyl group, an isothiazolyl group, anoxazolyl group, an isoxazolyl group, a pyridinyl group, a pyrazinylgroup, a pyrimidinyl group, a pyridazinyl group, an isoindolyl group, anindolyl group, an indazolyl group, a purinyl group, a quinolinyl group,an isoquinolinyl group, a benzoquinolinyl group, a phthalazinyl group, anaphthyridinyl group, a quinoxalinyl group, a quinazolinyl group, acinnolinyl group, a carbazolyl group, a phenanthridinyl group, anacridinyl group, a phenanthrolinyl group, a phenazinyl group, abenzoimidazolyl group, a benzofuranyl group, a benzothiophenyl group, anisobenzothiazolyl group, a benzoxazolyl group, an isobenzoxazolyl group,a triazolyl group, a tetrazolyl group, an oxadiazolyl group, a triazinylgroup, a dibenzofuranyl group, a dibenzothiophenyl group, abenzocarbazolyl group, a dibenzocarbazolyl group, a thiadiazolyl group,an imidazopyridinyl group, and an imidazopyrimidinyl group; and

a pyrrolyl group, a thiophenyl group, a furanyl group, an imidazolylgroup, a pyrazolyl group, a thiazolyl group, an isothiazolyl group, anoxazolyl group, an isoxazolyl group, a pyridinyl group, a pyrazinylgroup, a pyrimidinyl group, a pyridazinyl group, an isoindolyl group, anindolyl group, an indazolyl group, a purinyl group, a quinolinyl group,an isoquinolinyl group, a benzoquinolinyl group, a phthalazinyl group, anaphthyridinyl group, a quinoxalinyl group, a quinazolinyl group, acinnolinyl group, a carbazolyl group, a phenanthridinyl group, anacridinyl group, a phenanthrolinyl group, a phenazinyl group, abenzoimidazolyl group, a benzofuranyl group, a benzothiophenyl group, anisobenzothiazolyl group, a benzoxazolyl group, an isobenzoxazolyl group,a triazolyl group, a tetrazolyl group, an oxadiazolyl group, a triazinylgroup, a dibenzofuranyl group, a dibenzothiophenyl group, abenzocarbazolyl group, a dibenzocarbazolyl group, a thiadiazolyl group,an imidazopyridinyl group, and an imidazopyrimidinyl group, eachsubstituted with at least one selected from a deuterium, —F, —Cl, —Br,—I, a hydroxyl group, a cyano group, a nitro group, an amino group, anamidino group, a hydrazine group, a hydrazone group, a carboxylic acidor a salt thereof, a sulfonic acid or a salt thereof, a phosphoric acidor a salt thereof, a C₁-C₂₀ alkyl group, a C₁-C₂₀ alkoxy group, acyclopentyl group, a cyclohexyl group, a cycloheptyl group, acyclopentenyl group, a cyclohexenyl group, a phenyl group, a pentalenylgroup, an indenyl group, a naphthyl group, an azulenyl group, aheptalenyl group, an indacenyl group, an acenaphthyl group, a fluorenylgroup, a spiro-fluorenyl group, a benzofluorenyl group, adibenzofluorenyl group, a phenalenyl group, a phenanthrenyl group, ananthracenyl group, a fluoranthenyl group, a triphenylenyl group, apyrenyl group, a chrysenyl group, a naphthacenyl group, a picenyl group,a perylenyl group, a pentaphenyl group, a hexacenyl group, a pentacenylgroup, a rubicenyl group, a coronenyl group, an ovalenyl group, apyrrolyl group, a thiophenyl group, a furanyl group, an imidazolylgroup, a pyrazolyl group, a thiazolyl group, an isothiazolyl group, anoxazolyl group, an isoxazolyl group, a pyridinyl group, a pyrazinylgroup, a pyrimidinyl group, a pyridazinyl group, an isoindolyl group, anindolyl group, an indazolyl group, a purinyl group, a quinolinyl group,an isoquinolinyl group, a benzoquinolinyl group, a phthalazinyl group, anaphthyridinyl group, a quinoxalinyl group, a quinazolinyl group, acinnolinyl group, a carbazolyl group, a phenanthridinyl group, anacridinyl group, a phenanthrolinyl group, a phenazinyl group, abenzoimidazolyl group, a benzofuranyl group, a benzothiophenyl group, anisobenzothiazolyl group, a benzoxazolyl group, an isobenzoxazolyl group,a triazolyl group, a tetrazolyl group, an oxadiazolyl group, a triazinylgroup, a dibenzofuranyl group, a dibenzothiophenyl group, abenzocarbazolyl group, a dibenzocarbazolyl group, a thiadiazolyl group,an imidazopyridinyl group, and an imidazopyrimidinyl group;

xe1 may be selected from 0, 1, 2, and 3; and

xe2 may be selected from 1, 2, 3, and 4.

In Formula 602,

X₆₁₁ may be N or C-(L₆₁₁)_(xe611)-R₆₁₁, X₆₁₂ may be N orC-(L₆₁₂)_(xe612)-R₆₁₂, X₆₁₃ may be N or C-(L₆₁₃)_(xe613)-R₆₁₃, and atleast one selected from X₆₁₁ to X₆₁₃ may be N;

L₆₁₁ to L₆₁₆ may be each the same as defined in connection with L₂₀₁provided herein;

R₆₁₁ to R₆₁₆ may each independently be selected from:

a phenyl group, a naphthyl group, a fluorenyl group, a spiro-fluorenylgroup, a benzofluorenyl group, a dibenzofluorenyl group, a phenanthrenylgroup, an anthracenyl group, a pyrenyl group, a chrysenyl group, apyridinyl group, a pyrazinyl group, a pyrimidinyl group, a pyridazinylgroup, a quinolinyl group, an isoquinolinyl group, a quinoxalinyl group,a quinazolinyl group, a carbazolyl group, and a triazinyl group; and

a phenyl group, a naphthyl group, a fluorenyl group, a spiro-fluorenylgroup, a benzofluorenyl group, a dibenzofluorenyl group, a phenanthrenylgroup, an anthracenyl group, a pyrenyl group, a chrysenyl group, apyridinyl group, a pyrazinyl group, a pyrimidinyl group, a pyridazinylgroup, a quinolinyl group, an isoquinolinyl group, a quinoxalinyl group,a quinazolinyl group, a carbazolyl group, and a triazinyl group, eachsubstituted with at least one selected from a deuterium, —F, —Cl, —Br,—I, a hydroxyl group, a cyano group, a nitro group, an amino group, anamidino group, a hydrazine group, a hydrazone group, a carboxylic acidor a salt thereof, a sulfonic acid or a salt thereof, a phosphoric acidor a salt thereof, a C₁-C₂₀ alkyl group, a C₁-C₂₀ alkoxy group, a phenylgroup, a naphthyl group, a fluorenyl group, a spiro-fluorenyl group, abenzofluorenyl group, a dibenzofluorenyl group, a phenanthrenyl group,an anthracenyl group, a pyrenyl group, a chrysenyl group, a pyridinylgroup, a pyrazinyl group, a pyrimidinyl group, a pyridazinyl group, aquinolinyl group, an isoquinolinyl group, a quinoxalinyl group, aquinazolinyl group, a carbazolyl group, and a triazinyl group;

xe611 to xe616 may each independently be selected from 0, 1, 2, and 3.

The compound represented by Formula 601 and/or the compound representedby Formula 602 may each independently be one of Compounds ET1 to ET15illustrated below.

A thickness of the electron transport layer may be in a range of about100 Å to about 1,000 Å, e.g., about 150 Å to about 500 Å. When thethickness of the electron transport layer is within this range,excellent electron transport characteristics may be obtained without asubstantial increase in driving voltage.

The electron transport layer may further include a metal-containingmaterial in addition to the materials described above.

The metal-containing material may include a Li complex. The Li complexmay include, e.g., Compound ET-D1 (lithium quinolate, LiQ) or ET-D2.

The electron transport region may include an electron injection layerthat facilitates electron injection from the second electrode 190.

The electron injection layer may be formed on the electron transportlayer by using various methods, e.g., vacuum deposition, spin coating,casting, an LB method, inkjet printing, laser printing, or LITI. Whenthe electron injection layer is formed by vacuum deposition or spincoating, vacuum deposition and coating conditions for the electroninjection layer may be determined by referring to the vacuum depositionand coating conditions for the hole injection layer.

The electron injection layer may include, e.g., at least one selectedfrom LiF, NaCl, CsF, Li₂O, BaO, and LiQ.

A thickness of the electron injection layer may be in a range of about 1Å to about 100 Å, e.g., about 3 Å to about 90 Å. When the thickness ofthe electron injection layer is within this range, excellent electroninjection characteristics may be obtained without a substantial increasein driving voltage.

The second electrode 190 may be disposed on the organic layer 150. Thesecond electrode 190 may be a cathode that is an electron injectionelectrode, and in this regard, a material for forming the secondelectrode 190 may be a material having a low work function, and such amaterial may include metal, an alloy, an electrically conductivecompound, or a mixture thereof. Examples of the material for the secondelectrode 190 may include lithium (Li), magnesium (Mg), aluminum (Al),aluminum-lithium (Al—Li), calcium (Ca), magnesium-indium (Mg—In), ormagnesium-silver (Mg—Ag). In some embodiments, the material for formingthe second electrode 190 may be ITO or IZO. The second electrode 190 maybe a reflective electrode, a semi-transmissive electrode, or atransmissive electrode.

Hereinbefore, an organic light-emitting device has been described withreference to FIG. 1, but it is not limited thereto.

A C₁-C₆₀ alkyl group used herein refers to a linear or branchedaliphatic hydrocarbon monovalent group having 1 to 60 carbon atoms, anddetailed examples thereof are a methyl group, an ethyl group, a propylgroup, an isobutyl group, a sec-butyl group, a tert-butyl group, apentyl group, an iso-amyl group, or a hexyl group. A C₁-C₆₀ alkylenegroup used herein refers to a divalent group having the same structureas a C₁-C₆₀ alkyl group.

A C₁-C₆₀ alkoxy group used herein refers to a monovalent grouprepresented by —OA₁₀₁ (wherein A₁₀₁ is the C₁-C₆₀ alkyl group), anddetailed examples thereof are a methoxy group, an ethoxy group, or anisopropyloxy group.

A C₂-C₆₀ alkenyl group used herein refers to a hydrocarbon group formedby substituting at least one carbon double bond in the middle orterminal of the C₂-C₆₀ alkyl group, and detailed examples thereof are anethenyl group, a propenyl group, or a butenyl group. A C₂-C₆₀ alkenylenegroup used herein refers to a divalent group having the same structureas a C₂-C₆₀ alkenyl group.

A C₂-C₆₀ alkynyl group used herein refers to a hydrocarbon group formedby substituting at least one carbon triple bond in the middle orterminal of the C₂-C₆₀ alkyl group, and detailed examples thereof are anethynyl group or a propynyl group. A C₂-C₆₀ alkynylene group used hereinrefers to a divalent group having the same structure as a C₂-C₆₀ alkynylgroup.

A C₃-C₁₀ cycloalkyl group used herein refers to a monovalent monocyclicsaturated hydrocarbon group including 3 to 10 carbon atoms, and detailedexamples thereof are a cyclopropyl group, a cyclobutyl group, acyclopentyl group, a cyclohexyl group, or a cycloheptyl group. A C₃-C₁₀cycloalkylene group used herein refers to a divalent group having thesame structure as a C₃-C₁₀ cycloalkyl group.

A C₁-C₁₀ heterocycloalkyl group used herein refers to a monovalentmonocyclic group including at least one heteroatom selected from N, O,P, and S as a ring-forming atom and 1 to 10 carbon atoms, and detailedexamples thereof are a tetrahydrofuranyl group, or atetrahydrothiophenyl group. A C₁-C₁₀ heterocycloalkylene group usedherein refers to a divalent group having the same structure as a C₁-C₁₀heterocycloalkyl group.

A C₃-C₁₀ cycloalkenyl group used herein refers to a monovalentmonocyclic group including 3 to 10 carbon atoms and at least one doublebond in the ring thereof and does not have aromaticity, and detailedexamples thereof are a cyclopentenyl group, a cyclohexenyl group, or acycloheptenyl group. A C₃-C₁₀ cycloalkenylene group used herein refersto a divalent group having the same structure as a C₃-C₁₀ cycloalkenylgroup.

As used herein, a C₁-C₁₀ heterocycloalkenyl group refers to a monovalentmonocyclic group that has at least one hetero atom selected from N, O,P, and S as a ring-forming atom, 1 to 10 carbon atoms, and at least onedouble bond in its ring. Examples of the C₁-C₁₀ heterocycloalkenyl groupinclude a 2,3-dihydrofuranyl group and a 2,3-dihydrothiophenyl group. Asused herein, a C₁-C₁₀ heterocycloalkenylene group refers to a divalentgroup having the same structure as the C₁-C₁₀ heterocycloalkenyl group

A C₆-C₆₀ aryl group used herein refers to a monovalent group including acarbocyclic aromatic system having 6 to 60 carbon atoms, and a C₆-C₆₀arylene group used herein refers to a divalent group including acarbocyclic aromatic system having 6 to 60 carbon atoms. Detailedexamples of the C₆-C₆₀ aryl group are a phenyl group, a naphthyl group,an anthracenyl group, a phenanthrenyl group, a pyrenyl group, or achrysenyl group. When the C₆-C₆₀ aryl group and the C₆-C₆₀ arylene groupeach include two or more rings, the rings may be fused to each other.

A C₁-C₆₀ heteroaryl group used herein refers to a monovalent grouphaving a carbocyclic aromatic system including at least one heteroatomselected from N, O, P, and S as a ring-forming atom and 1 to 60 carbonatoms. A C₁-C₆₀ heteroarylene group used herein refers to a divalentgroup having a carbocyclic aromatic system including at least oneheteroatom selected from N, O, P, and S as a ring-forming atom and 1 to60 carbon atoms. Detailed examples of the C₁-C₆₀ heteroaryl group are apyridinyl group, a pyrimidinyl group, a pyrazinyl group, a pyridazinylgroup, a triazinyl group, a quinolinyl group, or an isoquinolinyl group.When the C₁-C₆₀ heteroaryl group and the C₁-C₆₀ heteroarylene group eachinclude two or more rings, the rings may be fused to each other.

A C₆-C₆₀ aryloxy group used herein indicates —OA₁₀₂ (wherein A₁₀₂ is theC₆-C₆₀ aryl group), and a C₆-C₆₀ arylthio group used herein indicates—SA₁₀₃ (wherein A₁₀₃ is the C₆-C₆₀ aryl group).

A monovalent non-aromatic condensed polycyclic group used herein refersto a monovalent group (for example, having 8 to 60 carbon atoms) thathas two or more rings condensed to each other and only carbon atoms as aring forming atoms, wherein the molecular structure as a whole isnon-aromatic in the entire molecular structure. A detailed example ofthe monovalent non-aromatic condensed polycyclic group is a fluorenylgroup. A divalent non-aromatic condensed polycyclic group used hereinrefers to a divalent group having the same structure as the monovalentnon-aromatic condensed polycyclic group.

As used herein, a monovalent non-aromatic condensed polycyclic grouprefers to a monovalent non-aromatic condensed polycyclic group that hastwo or more rings condensed to each other, only carbon atoms (forexample, the number of carbon atoms may be in a range of 8 to 60) as aring forming atom, and non-aromaticity in the entire molecularstructure. Examples of the monovalent non-aromatic condensed polycyclicgroup include a fluorenyl group. As used herein, a divalent non-aromaticcondensed polycyclic group refers to a divalent group having the samestructure as the monovalent non-aromatic condensed polycyclic group.

As used herein, at least one substituent of the substituted C₃-C₁₀cycloalkylene group, substituted C₁-C₁₀ heterocycloalkylene group,substituted C₃-C₁₀ cycloalkenylene group, substituted C₁-C₁₀heterocycloalkenylene group, substituted C₆-C₆₀ arylene group,substituted C₁-C₆₀ heteroarylene group, substituted divalentnon-aromatic condensed polycyclic group, substituted divalentnon-aromatic condensed heteropolycyclic group, substituted C₁-C₆₀ alkylgroup, substituted C₂-C₆₀ alkenyl group, substituted C₂-C₆₀ alkynylgroup, substituted C₁-C₆₀ alkoxy group, substituted C₃-C₁₀ cycloalkylgroup, substituted C₁-C₁₀ heterocycloalkyl group, substituted C₃-C₁₀cycloalkenyl group, substituted C₁-C₁₀ heterocycloalkenyl group,substituted C₆-C₆₀ aryl group, substituted C₆-C₆₀ aryloxy group,substituted C₆-C₆₀ arylthio group, substituted C₁-C₆₀ heteroaryl group,substituted monovalent non-aromatic condensed polycyclic group, andsubstituted monovalent non-aromatic condensed heteropolycyclic group isselected from

a C₁-C₆₀ alkyl group, a C₂-C₆₀ alkenyl group, a C₂-C₆₀ alkynyl group,and a C₁-C₆₀ alkoxy group, each substituted with at least one selectedfrom a deuterium, —F, —Cl, —Br, —I, a hydroxyl group, a cyano group, anitro group, an amino group, an amidino group, a hydrazine group, ahydrazone group, a carboxylic acid or a salt thereof, a sulfonic acid ora salt thereof, a phosphoric acid or a salt thereof, a C₃-C₁₀ cycloalkylgroup, a C₁-C₁₀ heterocycloalkyl group, a C₃-C₁₀ cycloalkenyl group, aC₁-C₁₀ heterocycloalkenyl group, a C₆-C₆₀ aryl group, a C₆-C₆₀ aryloxygroup, a C₆-C₆₀ arylthio group, a C₁-C₆₀ heteroaryl group, a monovalentnon-aromatic condensed polycyclic group, a monovalent non-aromaticcondensed heteropolycyclic group, —Si(Q₁₁)(Q₁₂)(Q₁₃), —B(Q₁₄)(Q₁₅), and—N(Q₁₆)(Q₁₇);

a C₃-C₁₀ cycloalkyl group, a C₁-C₁₀ heterocycloalkyl group, a C₃-C₁₀cycloalkenyl group, a C₁-C₁₀ heterocycloalkenyl group, a C₆-C₆₀ arylgroup, a C₆-C₆₀ aryloxy group, a C₆-C₆₀ arylthio group, a C₁-C₆₀heteroaryl group, a monovalent non-aromatic condensed polycyclic group,and a monovalent non-aromatic condensed heteropolycyclic group;

a C₃-C₁₀ cycloalkyl group, a C₁-C₁₀ heterocycloalkyl group, a C₃-C₁₀cycloalkenyl group, a C₁-C₁₀ heterocycloalkenyl group, a C₆-C₆₀ arylgroup, a C₆-C₆₀ aryloxy group, a C₆-C₆₀ arylthio group, a C₁-C₆₀heteroaryl group, a monovalent non-aromatic condensed polycyclic group,and a monovalent non-aromatic condensed heteropolycyclic group, eachsubstituted with at least one selected from a deuterium, —F, —Cl, —Br,—I, a hydroxyl group, a cyano group, a nitro group, an amino group, anamidino group, a hydrazine group, a hydrazone group, a carboxylic acidor a salt thereof, a sulfonic acid or a salt thereof, a phosphoric acidor a salt thereof, a C₁-C₆₀ alkyl group, a C₂-C₆₀ alkenyl group, aC₂-C₆₀ alkynyl group, a C₁-C₆₀ alkoxy group, a C₃-C₁₀ cycloalkyl group,a C₁-C₁₀ heterocycloalkyl group, a C₃-C₁₀ cycloalkenyl group, a C₁-C₁₀heterocycloalkenyl group, a C₆-C₆₀ aryl group, a C₆-C₆₀ aryloxy group, aC₆-C₆₀ arylthio group, a C₁-C₆₀ heteroaryl group, a monovalentnon-aromatic condensed polycyclic group, a monovalent non-aromaticcondensed heteropolycyclic group, —Si(Q₂₁)(Q₂₂)(Q₂₃), —B(Q₂₄)(Q₂₅), and—N(Q₂₆)(Q₂₇); and

—Si(Q₃₁)(Q₃₂)(Q₃₃), —B(Q₃₄)(Q₃₅), and —N(Q₃₆)(Q₃₇);

wherein Q₁₁ to Q₁₇, Q₂₁ to Q₂₇, and Q₃₁ to Q₃₇ may be each independentlyselected from a hydrogen, a deuterium, —F, —Cl, —Br, —I, a hydroxylgroup, a cyano group, a nitro group, an amino group, an amidino group, ahydrazine group, a hydrazone group, a carboxylic acid or a salt thereof,a sulfonic acid or a salt thereof, a phosphoric acid or a salt thereof,a C₁-C₆₀ alkyl group, a C₂-C₆₀ alkenyl group, a C₂-C₆₀ alkynyl group, aC₁-C₆₀ alkoxy group, a C₃-C₁₀ cycloalkyl group, a C₁-C₁₀heterocycloalkyl group, a C₃-C₁₀ cycloalkenyl group, a C₁-C₁₀heterocycloalkenyl group, a C₆-C₆₀ aryl group, a C₁-C₆₀ heteroarylgroup, a monovalent non-aromatic condensed polycyclic group, and amonovalent non-aromatic condensed heteropolycyclic group.

In some embodiments, at least one substituent of the substituted C₃-C₁₀cycloalkylene group, substituted C₁-C₁₀ heterocycloalkylene group,substituted C₃-C₁₀ cycloalkenylene group, substituted C₁-C₁₀heterocycloalkenylene group, substituted C₆-C₆₀ arylene group,substituted C₁-C₆₀ heteroarylene group, substituted divalentnon-aromatic condensed polycyclic group, substituted divalentnon-aromatic condensed heteropolycyclic group, substituted C₁-C₆₀ alkylgroup, substituted C₂-C₆₀ alkenyl group, substituted C₂-C₆₀ alkynylgroup, substituted C₁-C₆₀ alkoxy group, substituted C₃-C₁₀ cycloalkylgroup, substituted C₁-C₁₀ heterocycloalkyl group, substituted C₃-C₁₀cycloalkenyl group, substituted C₁-C₁₀ heterocycloalkenyl group,substituted C₆-C₆₀ aryl group, substituted C₆-C₆₀ aryloxy group,substituted C₆-C₆₀ arylthio group, substituted C₁-C₆₀ heteroaryl group,substituted monovalent non-aromatic condensed polycyclic group, andsubstituted monovalent non-aromatic condensed heteropolycyclic group maybe selected from

a deuterium, —F, —Cl, —Br, —I, a hydroxyl group, a cyano group, a nitrogroup, an amino group, an amidino group, a hydrazine group, a hydrazonegroup, a carboxylic acid or a salt thereof, a sulfonic acid or a saltthereof, a phosphoric acid or a salt thereof, a C₁-C₆₀ alkyl group, aC₂-C₆₀ alkenyl group, a C₂-C₆₀ alkynyl group, and a C₁-C₆₀ alkoxy group;

a C₁-C₆₀ alkyl group, a C₂-C₆₀ alkenyl group, a C₂-C₆₀ alkynyl group,and a C₁-C₆₀ alkoxy group, each substituted with at least one selectedfrom a deuterium, —F, —Cl, —Br, —I, a hydroxyl group, a cyano group, anitro group, an amino group, an amidino group, a hydrazine group, ahydrazone group, a carboxylic acid or a salt thereof, a sulfonic acid ora salt thereof, a phosphoric acid or a salt thereof, a cyclopentylgroup, a cyclohexyl group, a cycloheptyl group, a cyclopentenyl group, acyclohexenyl group, a phenyl group, a pentalenyl group, an indenylgroup, a naphthyl group, an azulenyl group, a heptalenyl group, anindacenyl group, an acenaphthyl group, a fluorenyl group, aspiro-fluorenyl group, a benzofluorenyl group, a dibenzofluorenyl group,a phenalenyl group, a phenanthrenyl group, an anthracenyl group, afluoranthenyl group, a triphenylenyl group, a pyrenyl group, a chrysenylgroup, a naphthacenyl group, a picenyl group, a perylenyl group, apentaphenyl group, a hexacenyl group, a pentacenyl group, a rubicenylgroup, a coronenyl group, an ovalenyl group, a pyrrolyl group, athiophenyl group, a furanyl group, an imidazolyl group, a pyrazolylgroup, a thiazolyl group, an isothiazolyl group, an oxazolyl group, anisoxazolyl group, a pyridinyl group, a pyrazinyl group, a pyrimidinylgroup, a pyridazinyl group, an isoindolyl group, an indolyl group, anindazolyl group, a purinyl group, a quinolinyl group, an isoquinolinylgroup, a benzoquinolinyl group, a phthalazinyl group, a naphthyridinylgroup, a quinoxalinyl group, a quinazolinyl group, a cinnolinyl group, acarbazolyl group, a phenanthridinyl group, an acridinyl group, aphenanthrolinyl group, a phenazinyl group, a benzoimidazolyl group, abenzofuranyl group, a benzothiophenyl group, an isobenzothiazolyl group,a benzoxazolyl group, an isobenzoxazolyl group, a triazolyl group, atetrazolyl group, an oxadiazolyl group, a triazinyl group, adibenzofuranyl group, a dibenzothiophenyl group, a benzocarbazolylgroup, a dibenzocarbazolyl group, a thiadiazolyl group, animidazopyridinyl group, an imidazopyrimidinyl group, —N(Q₁₁)(Q₁₂),—B(Q₁₃)(Q₁₄), and —Si(Q₁₅)(Q₁₆)(Q₁₇);

a cyclopentyl group, a cyclohexyl group, a cycloheptyl group, acyclopentenyl group, a cyclohexenyl group, a phenyl group, a pentalenylgroup, an indenyl group, a naphthyl group, an azulenyl group, aheptalenyl group, an indacenyl group, an acenaphthyl group, a fluorenylgroup, a spiro-fluorenyl group, a benzofluorenyl group, adibenzofluorenyl group, a phenalenyl group, a phenanthrenyl group, ananthracenyl group, a fluoranthenyl group, a triphenylenyl group, apyrenyl group, a chrysenyl group, a naphthacenyl group, a picenyl group,a perylenyl group, a pentaphenyl group, a hexacenyl group, a pentacenylgroup, a rubicenyl group, a coronenyl group, an ovalenyl group, apyrrolyl group, a thiophenyl group, a furanyl group, an imidazolylgroup, a pyrazolyl group, a thiazolyl group, an isothiazolyl group, anoxazolyl group, an isoxazolyl group, a pyridinyl group, a pyrazinylgroup, a pyrimidinyl group, a pyridazinyl group, an isoindolyl group, anindolyl group, an indazolyl group, a purinyl group, a quinolinyl group,an isoquinolinyl group, a benzoquinolinyl group, a phthalazinyl group, anaphthyridinyl group, a quinoxalinyl group, a quinazolinyl group, acinnolinyl group, a carbazolyl group, a phenanthridinyl group, anacridinyl group, a phenanthrolinyl group, a phenazinyl group, abenzoimidazolyl group, a benzofuranyl group, a benzothiophenyl group, anisobenzothiazolyl group, a benzoxazolyl group, an isobenzoxazolyl group,a triazolyl group, a tetrazolyl group, an oxadiazolyl group, a triazinylgroup, a dibenzofuranyl group, a dibenzothiophenyl group, abenzocarbazolyl group, a dibenzocarbazolyl group, a thiadiazolyl group,an imidazopyridinyl group, and an imidazopyrimidinyl group;

a cyclopentyl group, a cyclohexyl group, a cycloheptyl group, acyclopentenyl group, a cyclohexenyl group, a phenyl group, a pentalenylgroup, an indenyl group, a naphthyl group, an azulenyl group, aheptalenyl group, an indacenyl group, an acenaphthyl group, a fluorenylgroup, a spiro-fluorenyl group, a benzofluorenyl group, adibenzofluorenyl group, a phenalenyl group, a phenanthrenyl group, ananthracenyl group, a fluoranthenyl group, a triphenylenyl group, apyrenyl group, a chrysenyl group, a naphthacenyl group, a picenyl group,a perylenyl group, a pentaphenyl group, a hexacenyl group, a pentacenylgroup, a rubicenyl group, a coronenyl group, an ovalenyl group, apyrrolyl group, a thiophenyl group, a furanyl group, an imidazolylgroup, a pyrazolyl group, a thiazolyl group, an isothiazolyl group, anoxazolyl group, an isoxazolyl group, a pyridinyl group, a pyrazinylgroup, a pyrimidinyl group, a pyridazinyl group, an isoindolyl group, anindolyl group, an indazolyl group, a purinyl group, a quinolinyl group,an isoquinolinyl group, a benzoquinolinyl group, a phthalazinyl group, anaphthyridinyl group, a quinoxalinyl group, a quinazolinyl group, acinnolinyl group, a carbazolyl group, a phenanthridinyl group, anacridinyl group, a phenanthrolinyl group, a phenazinyl group, abenzoimidazolyl group, a benzofuranyl group, a benzothiophenyl group, anisobenzothiazolyl group, a benzoxazolyl group, an isobenzoxazolyl group,a triazolyl group, a tetrazolyl group, an oxadiazolyl group, a triazinylgroup, a dibenzofuranyl group, a dibenzothiophenyl group, abenzocarbazolyl group, a dibenzocarbazolyl group, a thiadiazolyl group,an imidazopyridinyl group, and an imidazopyrimidinyl group, eachsubstituted with at least one selected from a deuterium, —F, —Cl, —Br,—I, a hydroxyl group, a cyano group, a nitro group, an amino group, anamidino group, a hydrazine group, a hydrazone group, a carboxylic acidor a salt thereof, a sulfonic acid or a salt thereof, a phosphoric acidor a salt thereof, a C₁-C₆₀ alkyl group, a C₂-C₆₀ alkenyl group, aC₂-C₆₀ alkynyl group, a C₁-C₆₀ alkoxy group, a cyclopentyl group, acyclohexyl group, a cycloheptyl group, a cyclopentenyl group, acyclohexenyl group, a phenyl group, a pentalenyl group, an indenylgroup, a naphthyl group, an azulenyl group, a heptalenyl group, anindacenyl group, an acenaphthyl group, a fluorenyl group, aspiro-fluorenyl group, a benzofluorenyl group, a dibenzofluorenyl group,a phenalenyl group, a phenanthrenyl group, an anthracenyl group, afluoranthenyl group, a triphenylenyl group, a pyrenyl group, a chrysenylgroup, a naphthacenyl group, a picenyl group, a perylenyl group, apentaphenyl group, a hexacenyl group, a pentacenyl group, a rubicenylgroup, a coronenyl group, an ovalenyl group, a pyrrolyl group, athiophenyl group, a furanyl group, an imidazolyl group, a pyrazolylgroup, a thiazolyl group, an isothiazolyl group, an oxazolyl group, anisoxazolyl group, a pyridinyl group, a pyrazinyl group, a pyrimidinylgroup, a pyridazinyl group, an isoindolyl group, an indolyl group, anindazolyl group, a purinyl group, a quinolinyl group, an isoquinolinylgroup, a benzoquinolinyl group, a phthalazinyl group, a naphthyridinylgroup, a quinoxalinyl group, a quinazolinyl group, a cinnolinyl group, acarbazolyl group, a phenanthridinyl group, an acridinyl group, aphenanthrolinyl group, a phenazinyl group, a benzoimidazolyl group, abenzofuranyl group, a benzothiophenyl group, an isobenzothiazolyl group,a benzoxazolyl group, an isobenzoxazolyl group, a triazolyl group, atetrazolyl group, an oxadiazolyl group, a triazinyl group, adibenzofuranyl group, a dibenzothiophenyl group, a benzocarbazolylgroup, a dibenzocarbazolyl group, a thiadiazolyl group, animidazopyridinyl group, an imidazopyrimidinyl group, —N(Q₂₁)(Q₂₂),—B(Q₂₃)(Q₂₄), and —Si(Q₂₅)(Q₂₆)(Q₂₇); and

—N(Q₃₁)(Q₃₂), —B(Q₃₃)(Q₃₄), and —Si(Q₃₅)(Q₃₆)(Q₃₇);

wherein Q₁₁ to Q₁₇, Q₂₁ to Q₂₇, and Q₃₁ to Q₃₇ may be each independentlyselected from a hydrogen, a deuterium, —F, —Cl, —Br, —I, a hydroxylgroup, a cyano group, a nitro group, an amino group, an amidino group, ahydrazine group, a hydrazone group, a carboxylic acid or a salt thereof,a sulfonic acid or a salt thereof, a phosphoric acid or a salt thereof,a C₁-C₆₀ alkyl group, a C₂-C₆₀ alkenyl group, a C₂-C₆₀ alkynyl group, aC₁-C₆₀ alkoxy group, a cyclopentyl group, a cyclohexyl group, acycloheptyl group, a cyclopentenyl group, a cyclohexenyl group, a phenylgroup, a pentalenyl group, an indenyl group, a naphthyl group, anazulenyl group, a heptalenyl group, an indacenyl group, an acenaphthylgroup, a fluorenyl group, a spiro-fluorenyl group, a benzofluorenylgroup, a dibenzofluorenyl group, a phenalenyl group, a phenanthrenylgroup, an anthracenyl group, a fluoranthenyl group, a triphenylenylgroup, a pyrenyl group, a chrysenyl group, a naphthacenyl group, apicenyl group, a perylenyl group, a pentaphenyl group, a hexacenylgroup, a pentacenyl group, a rubicenyl group, a coronenyl group, anovalenyl group, a pyrrolyl group, a thiophenyl group, a furanyl group,an imidazolyl group, a pyrazolyl group, a thiazolyl group, anisothiazolyl group, an oxazolyl group, an isoxazolyl group, a pyridinylgroup, a pyrazinyl group, a pyrimidinyl group, a pyridazinyl group, anisoindolyl group, an indolyl group, an indazolyl group, a purinyl group,a quinolinyl group, an isoquinolinyl group, a benzoquinolinyl group, aphthalazinyl group, a naphthyridinyl group, a quinoxalinyl group, aquinazolinyl group, a cinnolinyl group, a carbazolyl group, aphenanthridinyl group, an acridinyl group, a phenanthrolinyl group, aphenazinyl group, a benzoimidazolyl group, a benzofuranyl group, abenzothiophenyl group, an isobenzothiazolyl group, a benzoxazolyl group,an isobenzoxazolyl group, a triazolyl group, a tetrazolyl group, anoxadiazolyl group, a triazinyl group, a dibenzofuranyl group, adibenzothiophenyl group, a benzocarbazolyl group, a dibenzocarbazolylgroup, a thiadiazolyl group, an imidazopyridinyl group, and animidazopyrimidinyl group, but embodiments are not limited thereto.

Hereinafter, an organic light-emitting device according to exemplaryembodiments are described in detail with reference to Synthesis Examplesand Examples. However, the organic light-emitting device is not limitedthereto.

The following Examples and Comparative Examples are provided in order tohighlight characteristics of one or more embodiments, but it will beunderstood that the Examples and Comparative Examples are not to beconstrued as limiting the scope of the embodiments, nor are theComparative Examples to be construed as being outside the scope of theembodiments. Further, it will be understood that the embodiments are notlimited to the particular details described in the Examples andComparative Examples.

EXAMPLES Synthesis Example 1 Synthesis of Compound 1

1.4 g (4 mmol) of Intermediate A, 1.6 g (4 mmol) of Intermediate B, 231mg (0.2 mmol) of Pd(PPh₃)₄, and 1.1 g (12 mmol) of sodium t-butoxidewere added to 100 ml of toluene and 25 ml of ethanol in a nitrogenatmosphere and refluxed for 24 hours. When the reaction was completed,the solvent was evaporated, and 800 ml of methylene chloride and 800 mlof water were added thereto to wash the mixture. Then, an organic layerobtained therefrom was dried with anhydrous magnesium sulfate.Subsequently, the resultant was recrystallized and purified throughsilica gel chromatography, and thus, 1.6 g of Compound 1 (yield: 40%)was obtained.

MS (MALDI-TOF) m/z: 545 [M]+.

Synthesis Example 2 Synthesis of Compound 4

1.2 g of Compound 4 (yield: 43%) was synthesized in the same manner asin the synthesis method of Compound 1, except that Intermediate C wasused instead of Intermediate A.

MS (MALDI-TOF) m/z: 621 [M]+.

Synthesis Example 3 Synthesis of Compound 7

1.6 g of Compound 7 (yield: 45%) was synthesized in the same manner asin the synthesis method of Compound 1, except that Intermediate D wasused instead of Intermediate A.

MS (MALDI-TOF) m/z: 621 [M]+.

Synthesis Example 4 Synthesis of Compound 26

0.9 g of Compound 26 (yield: 33%) was synthesized in the same manner asin the synthesis method of Compound 1, except that Intermediate E wasused instead of Intermediate B.

MS (MALDI-TOF) m/z: 545 [M]+.

Synthesis Example 5 Synthesis of Compound 28

1.2 g of Compound 28 (yield: 30%) was synthesized in the same manner asin the synthesis method of Compound 1, except that Intermediate F wasused instead of Intermediate A.

MS (MALDI-TOF) m/z: 671 [M]+.

Synthesis Example 6 Synthesis of Compound 32

1.1 g of Compound 32 (yield: 29%) was synthesized in the same manner asin the synthesis method of Compound 1, except that Intermediate F wasused instead of Intermediate A, and Intermediate E was used instead ofIntermediate B.

MS (MALDI-TOF) m/z: 671 [M]+.

Synthesis Example 7 Synthesis of Compound 36

1.4 g of Compound 36 (yield: 45%) was synthesized in the same manner asin the synthesis method of Compound 1, except that Intermediate C wasused instead of Intermediate A, and Intermediate E was used instead ofIntermediate B.

MS (MALDI-TOF) m/z: 621 [M]+.

Synthesis Example 8 Synthesis of Compound 37

1.5 g of Compound 37 (yield: 46%) was synthesized in the same manner asin the synthesis method of Compound 1, except that Intermediate D wasused instead of Intermediate A, and Intermediate E was used instead ofIntermediate B.

MS (MALDI-TOF) m/z: 621 [M]+.

Example 1

A indium tin oxide (ITO) glass substrate (available from Corning) havinga sheet resistance and thickness of 15 Ω/cm² and 1,200 Å was cut to asize of 50 mm×50 mm×0.5 mm, sonicated in isopropyl alcohol and purewater for 15 minutes each, and then cleaned with UV and ozone for 30minutes. The ITO glass substrate was then mounted on a vacuum depositor.

Compound HT-3 was deposited on the ITO glass substrate to form a holeinjection layer having a thickness of 600 Å, NPB was deposited on thehole injection layer to form a hole transport layer having a thicknessof 300 Å, and then Compound 1 (a host) and PD1 (a dopant) wereco-deposited at a weight ratio of 0.15:1 on the hole transport layer toform an emission layer having a thickness of 400 Å.

BCP was deposited on the emission layer to form an electron transportlayer having a thickness of 100 Å, LiF was deposited on the electrontransport layer to form an electron injection layer having a thicknessof 10 Å, and Al was deposited on the electrode injection layer to form acathode having a thickness of 2,000 Å, thereby completing manufacture ofan organic light-emitting device.

Example 2

An organic light-emitting device was manufactured in the same manner asin Example 1, except that Compound 4 was used instead of Compound 1 as ahost in the formation of the emission layer.

Example 3

An organic light-emitting device was manufactured in the same manner asin Example 1, except that Compound 7 was used instead of Compound 1 as ahost in the formation of the emission layer.

Example 4

An organic light-emitting device was manufactured in the same manner asin Example 1, except that Compound 26 was used instead of Compound 1 asa host in the formation of the emission layer.

Example 5

An organic light-emitting device was manufactured in the same manner asin Example 1, except that Compound 28 was used instead of Compound 1 asa host in the formation of the emission layer.

Example 6

An organic light-emitting device was manufactured in the same manner asin Example 1, except that Compound 32 was used instead of Compound 1 asa host in the formation of the emission layer.

Example 7

An organic light-emitting device was manufactured in the same manner asin Example 1, except that Compound 36 was used instead of Compound 1 asa host in the formation of the emission layer.

Example 8

An organic light-emitting device was manufactured in the same manner asin Example 1, except that Compound 37 was used instead of Compound 1 asa host in the formation of the emission layer.

Comparative Example 1

An organic light-emitting device was manufactured in the same manner asin Example 1, except that Compound A, below, was used instead ofCompound 1 as a host in the formation of the emission layer:

Comparative Example 2

An organic light-emitting device was manufactured in the same manner asin Example 1, except that Compound B, below, was used instead ofCompound 1 as a host in the formation of the emission layer:

Comparative Example 3

An organic light-emitting device was manufactured in the same manner asin Example 1, except that Compound C, below, was used instead ofCompound 1 as a host in the formation of the emission layer:

Comparative Example 4

An organic light-emitting device was manufactured in the same manner asin Example 1, except that Compound D, below, was used instead ofCompound 1 as a host in the formation of the emission layer:

Evaluation Example 1

Driving voltages, luminances, efficiencies, and lifespans (T₉₀) data ofthe organic light-emitting devices prepared in Examples 1 to 8 andComparative Examples 1 and 4 were measured by using Kethley SMU 236 anda luminance meter PR650, and the results are shown in Table 1. Thelifespan (T₉₀) is defined as the time for the luminance of an organiclight-emitting device to decline to 90% of its initial luminance.

TABLE 1 Lifespan Driving Color of (T₉₀) (hr) Emission layer voltageLuminance Efficiency emitted (@3000 (host) (V) (cd/m²) (cd/A) lightcd/m²) Example 1 Compound 1 5.2 3000 52 green 125 Example 2 Compound 45.3 3000 55 green 105 Example 3 Compound 7 5.4 3000 59 green 109 Example4 Compound 26 5.3 3000 54 green 112 Example 5 Compound 28 5.4 3000 53green 124 Example 6 Compound 32 5.2 3000 57 green 109 Example 7 Compound36 5.3 3000 59 green 111 Example 8 Compound 37 5.2 3000 53 green 131Comparative Compound A 5.8 3000 28 green 60 Example 1 ComparativeCompound B 5.9 3000 27 green 52 Example 2 Comparative Compound C 5.73000 12 green 20 Example 3 Comparative Compound D 5.8 3000 30 green 40Example 4

As shown in Table 1, driving voltages, luminances, efficiencies, andlifespans (T₉₀) of the organic light-emitting devices prepared inExamples 1 to 8 were excellent, compared to those of the organiclight-emitting device prepared in Comparative Examples 1 and 4.

As described above, according to the one or more of the aboveembodiments, an organic light-emitting device including the condensedcyclic compound may have a low driving voltage, high efficiency, highluminance, and a long lifespan.

Example embodiments have been disclosed herein, and although specificterms are employed, they are used and are to be interpreted in a genericand descriptive sense only and not for purpose of limitation. In someinstances, as would be apparent to one of ordinary skill in the art asof the filing of the present application, features, characteristics,and/or elements described in connection with a particular embodiment maybe used singly or in combination with features, characteristics, and/orelements described in connection with other embodiments unless otherwisespecifically indicated. Accordingly, it will be understood by those ofskill in the art that various changes in form and details may be madewithout departing from the spirit and scope of the present invention asset forth in the following claims.

What is claimed is:
 1. A condensed cyclic compound represented byFormula 1:(A₁)_(a1)-(L₁)_(b1)-(A₂)_(a2)  <Formula 1> wherein, in Formula 1, A₁ isa group represented by Formula 2-1, below, a1 is 1, 2, or 3, and, whena1 is 2 or greater, two or more A₁ s are identical to or different fromeach other, A₂ is a group represented by Formula 2-2, below, a2 is 1, 2,or 3, and, when a2 is 2 or greater, two or more A₂s are identical to ordifferent from each other,

wherein, in Formulae 1, 2-1, and 2-2, L₁ and L₂ are each independentlyselected from a substituted or unsubstituted C₃-C₁₀ cycloalkylene group,a substituted or unsubstituted heterocycloalkylene group, a substitutedor unsubstituted C₃-C₁₀ cycloalkenylene group, a substituted orunsubstituted C₁-C₁₀ heterocycloalkenylene group, a substituted orunsubstituted C₆-C₆₀ arylene group, a substituted or unsubstitutedC₁-C₆₀ heteroarylene group, a substituted or unsubstituted divalentnon-aromatic condensed polycyclic group, and a substituted orunsubstituted divalent non-aromatic condensed heteropolycyclic group,provided that L₂ is not a substituted or unsubstituted triphenylenylenegroup, b1 and b2 are each independently selected from 0, 1, 2, and 3;when b1 or b2 is 0, *-(L₁)_(b1)-*′ or *-(L₂)_(b2)-*′ is a single bond,when b1 is 2 or greater, two or more L₁s are identical to or differentfrom each other, and when b2 is 2 or greater, two or more L₂s areidentical to or different from each other, Ar₁ is selected from asubstituted or unsubstituted C₃-C₁₀ cycloalkyl group, a substituted orunsubstituted C₁-C₁₀ heterocycloalkyl group, a substituted orunsubstituted C₃-C₁₀ cycloalkenyl group, a substituted or unsubstitutedC₁-C₁₀ heterocycloalkenyl group, a substituted or unsubstituted C₆-C₆₀aryl group, a substituted or unsubstituted C₁-C₆₀ heteroaryl group, asubstituted or unsubstituted monovalent non-aromatic condensedpolycyclic group, and a substituted or unsubstituted monovalentnon-aromatic condensed heteropolycyclic group, provided that Ar₁ is nota substituted or unsubstituted triphenylenyl group, R₁ to R₁₂ and R₂₁ toR₃₂ are each independently selected from a binding site to one of A₁,L₁, and A₂ in Formula 1, a hydrogen, a deuterium, —F, —Cl, —Br, —I, ahydroxyl group, a cyano group, a nitro group, an amino group, an amidinogroup, a hydrazine group, a hydrazone group, a carboxylic acid or a saltthereof, a sulfonic acid or a salt thereof, a phosphoric acid or a saltthereof, a substituted or unsubstituted C₁-C₆₀ alkyl group, asubstituted or unsubstituted C₂-C₆₀ alkenyl group, a substituted orunsubstituted C₂-C₆₀ alkynyl group, a substituted or unsubstitutedC₁-C₆₀ alkoxy group, a substituted or unsubstituted C₃-C₁₀ cycloalkylgroup, a substituted or unsubstituted C₁-C₁₀ heterocycloalkyl group, asubstituted or unsubstituted C₃-C₁₀ cycloalkenyl group, a substituted orunsubstituted C₁-C₁₀ heterocycloalkenyl group, a substituted orunsubstituted C₆-C₆₀ aryl group, a substituted or unsubstituted C₆-C₆₀aryloxy group, a substituted or unsubstituted C₆-C₆₀ arylthio group, asubstituted or unsubstituted C₁-C₆₀ heteroaryl group, a substituted orunsubstituted monovalent non-aromatic condensed polycyclic group, asubstituted or unsubstituted monovalent non-aromatic condensedheteropolycyclic group, —Si(Q₁)(Q₂)(Q₃), —B(Q₄)(Q₅), and N(Q₆)(Q₇), anumber of R₁ to R₁₂ that are a binding site to L₁ or A₂ in Formula 1 isequal to a1, and a number of R₂₁ to R₃₂ that are a binding site to L₁ orA₂ in Formula 1 is equal to a2; at least one substituent of thesubstituted C₃-C₁₀ cycloalkylene group, substituted C₁-C₁₀heterocycloalkylene group, substituted C₃-C₁₀ cycloalkenylene group,substituted C₁-C₁₀ heterocycloalkenylene group, substituted C₆-C₆₀arylene group, substituted C₁-C₆₀ heteroarylene group, substituteddivalent non-aromatic condensed polycyclic group, substituted divalentnon-aromatic condensed heteropolycyclic group, substituted C₁-C₆₀ alkylgroup, substituted C₂-C₆₀ alkenyl group, substituted C₂-C₆₀ alkynylgroup, substituted C₁-C₆₀ alkoxy group, substituted C₃-C₁₀ cycloalkylgroup, substituted C₁-C₁₀ heterocycloalkyl group, substituted C₃-C₁₀cycloalkenyl group, substituted C₁-C₁₀ heterocycloalkenyl group,substituted C₆-C₆₀ aryl group, substituted C₆-C₆₀ aryloxy group,substituted C₆-C₆₀ arylthio group, substituted C₁-C₆₀ heteroaryl group,substituted monovalent non-aromatic condensed polycyclic group, andsubstituted monovalent non-aromatic condensed heteropolycyclic group isselected from: a deuterium, —F, —Cl, —Br, —I, a hydroxyl group, a cyanogroup, a nitro group, an amino group, an amidino group, a hydrazinegroup, a hydrazone group, a carboxylic acid or a salt thereof, asulfonic acid or a salt thereof, a phosphoric acid or a salt thereof, aC₁-C₆₀ alkyl group, a C₂-C₆₀ alkenyl group, a C₂-C₆₀ alkynyl group, anda C₁-C₆₀ alkoxy group; a C₁-C₆₀ alkyl group, a C₂-C₆₀ alkenyl group, aC₂-C₆₀ alkynyl group, and a C₁-C₆₀ alkoxy group, each substituted withat least one selected from a deuterium, —F, —Cl, —Br, —I, a hydroxylgroup, a cyano group, a nitro group, an amino group, an amidino group, ahydrazine group, a hydrazone group, a carboxylic acid or a salt thereof,a sulfonic acid or a salt thereof, a phosphoric acid or a salt thereof,a C₃-C₁₀ cycloalkyl group, a C₁-C₁₀ heterocycloalkyl group, a C₃-C₁₀cycloalkenyl group, a C₁-C₁₀ heterocycloalkenyl group, a C₆-C₆₀ arylgroup, a C₆-C₆₀ aryloxy group, a C₆-C₆₀ arylthio group, a C₁-C₆₀heteroaryl group, a monovalent non-aromatic condensed polycyclic group,a monovalent non-aromatic condensed heteropolycyclic group,—Si(Q₁₁)(Q₁₂)(Q₁₃), —B(Q₁₄)(Q₁₅), and —N(Q₁₆)(Q₁₇); a C₃-C₁₀ cycloalkylgroup, a C₁-C₁₀heterocycloalkyl group, a C₃-C₁₀ cycloalkenyl group, aC₁-C₁₀ heterocycloalkenyl group, a C₆-C₆₀ aryl group, a C₆-C₆₀ aryloxygroup, a C₆-C₆₀ arylthio group, a C₁-C₆₀ heteroaryl group, a monovalentnon-aromatic condensed polycyclic group, and a monovalent non-aromaticcondensed heteropolycyclic group; a C₃-C₁₀ cycloalkyl group, a C₁-C₁₀heterocycloalkyl group, a C₃-C₁₀ cycloalkenyl group, a C₁-C₁₀heterocycloalkenyl group, a C₆-C₆₀ aryl group, a C₆-C₆₀ aryloxy group, aC₆-C₆₀ arylthio group, a C₁-C₆₀ heteroaryl group, a monovalentnon-aromatic condensed polycyclic group, and a monovalent non-aromaticcondensed heteropolycyclic group, each substituted with at least oneselected from a deuterium, —F, —Cl, —Br, —I, a hydroxyl group, a cyanogroup, a nitro group, an amino group, an amidino group, a hydrazinegroup, a hydrazone group, a carboxylic acid or a salt thereof, asulfonic acid or a salt thereof, a phosphoric acid or a salt thereof, aC₁-C₆₀ alkyl group, a C₂-C₆₀ alkenyl group, a C₂-C₆₀ alkynyl group, aC₁-C₆₀ alkoxy group, a C₃-C₁₀ cycloalkyl group, a C₁-C₁₀heterocycloalkyl group, a C₃-C₁₀ cycloalkenyl group, a C₁-C₁₀heterocycloalkenyl group, a C₆-C₆₀ aryl group, a C₆-C₆₀ aryloxy group, aC₆-C₆₀ arylthio group, a C₁-C₆₀ heteroaryl group, a monovalentnon-aromatic condensed polycyclic group, a monovalent non-aromaticcondensed heteropolycyclic group, —Si(Q₂₁)(Q₂₂)(Q₂₃), —B(Q₂₄)(Q₂₅), and—N(Q₂₆)(Q₂₇); and —Si(Q₃₁)(Q₃₂)(Q₃₃), —B(Q₃₄)(Q₃₅), and —N(Q₃₆)(Q₃₇);wherein Q₁ to Q₇, Q₁₁ to Q₁₇, Q₂₁ to Q₂₇, and Q₃₁ to Q₃₇ are eachindependently selected from a hydrogen, a deuterium, —F, —Cl, —Br, —I, ahydroxyl group, a cyano group, a nitro group, an amino group, an amidinogroup, a hydrazine group, a hydrazone group, a carboxylic acid or a saltthereof, a sulfonic acid or a salt thereof, a phosphoric acid or a saltthereof, a C₁-C₆₀ alkyl group, a C₂-C₆₀ alkenyl group, a C₂-C₆₀ alkynylgroup, a C₁-C₆₀ alkoxy group, a C₃-C₁₀ cycloalkyl group, a C₁-C₁₀heterocycloalkyl group, a C₃-C₁₀ cycloalkenyl group, a C₁-C₁₀heterocycloalkenyl group, a C₆-C₆₀ aryl group, a C₁-C₆₀ heteroarylgroup, a monovalent non-aromatic condensed polycyclic group, and amonovalent non-aromatic condensed heteropolycyclic group.
 2. Thecondensed cyclic compound as claimed in claim 1, wherein a1 and a2 areeach independently 1 or
 2. 3. The condensed cyclic compound as claimedin claim 1, wherein L₁ and L₂ are each independently selected from: aphenylene group, a pentalenylene group, an indenylene group, anaphthylene group, an azulenylene group, a heptalenylene group, anindacenylene group, an acenaphthylene group, a fluorenylene group, aspiro-fluorenylene group, a benzofluorenylene group, adibenzofluorenylene group, a phenalenylene group, a phenanthrenylenegroup, an anthracenylene group, a fluoranthenylene group, a pyrenylenegroup, a chrysenylene group, a naphthacenylene group, a picenylenegroup, a perylenylene group, a pentaphenylene group, a hexacenylenegroup, a pentacenylene group, a rubicenylene group, a coronenylenegroup, an ovalenylene group, a pyrrolylene group, a thiophenylene group,a furanylene group, an imidazolylene group, a pyrazolylene group, athiazolylene group, an isothiazolylene group, an oxazolylene group, anisoxazolylene group, a pyridinylene group, a pyrazinylene group, apyrimidinylene group, a pyridazinylene group, an isoindolylene group, anindolylene group, an indazolylene group, a purinylene group, aquinolinylene group, an isoquinolinylene group, a benzoquinolinylenegroup, a phthalazinylene group, a naphthyridinylene group, aquinoxalinylene group, a quinazolinylene group, a cinnolinylene group, acarbazolylene group, a phenanthridinylene group, an acridinylene group,a phenanthrolinylene group, a phenazinylene group, a benzoimidazolylenegroup, a benzofuranylene group, a benzothiophenylene group, anisobenzothiazolylene group, a benzoxazolylene group, anisobenzoxazolylene group, a triazolylene group, a tetrazolylene group,an oxadiazolylene group, a triazinylene group, a dibenzofuranylenegroup, a dibenzothiophenylene group, a benzocarbazolylene group, adibenzocarbazolylene group, a thiadiazolylene group, animidazopyridinylene group, and an imidazopyrimidinylene group; and aphenylene group, a pentalenylene group, an indenylene group, anaphthylene group, an azulenylene group, a heptalenylene group, anindacenylene group, an acenaphthylene group, a fluorenylene group, aspiro-fluorenylene group, a benzofluorenylene group, adibenzofluorenylene group, a phenalenylene group, a phenanthrenylenegroup, an anthracenylene group, a fluoranthenylene group, a pyrenylenegroup, a chrysenylene group, a naphthacenylene group, a picenylenegroup, a perylenylene group, a pentaphenylene group, a hexacenylenegroup, a pentacenylene group, a rubicenylene group, a coronenylenegroup, an ovalenylene group, a pyrrolylene group, a thiophenylene group,a furanylene group, an imidazolylene group, a pyrazolylene group, athiazolylene group, an isothiazolylene group, an oxazolylene group, anisoxazolylene group, a pyridinylene group, a pyrazinylene group, apyrimidinylene group, a pyridazinylene group, an isoindolylene group, anindolylene group, an indazolylene group, a purinylene group, aquinolinylene group, an isoquinolinylene group, a benzoquinolinylenegroup, a phthalazinylene group, a naphthyridinylene group, aquinoxalinylene group, a quinazolinylene group, a cinnolinylene group, acarbazolylene group, a phenanthridinylene group, an acridinylene group,a phenanthrolinylene group, a phenazinylene group, a benzoimidazolylenegroup, a benzofuranylene group, a benzothiophenylene group, anisobenzothiazolylene group, a benzoxazolylene group, anisobenzoxazolylene group, a triazolylene group, a tetrazolylene group,an oxadiazolylene group, a triazinylene group, a dibenzofuranylenegroup, a dibenzothiophenylene group, a benzocarbazolylene group, adibenzocarbazolylene group, a thiadiazolylene group, animidazopyridinylene group, and an imidazopyrimidinylene group, eachsubstituted with at least one selected from a deuterium, —F, —Br, —I, ahydroxyl group, a cyano group, a nitro group, an amino group, an amidinogroup, a hydrazine group, a hydrazone group, a carboxylic acid or a saltthereof, a sulfonic acid or a salt thereof, a phosphoric acid or a saltthereof, C₁-C₂₀ alkyl group, C₁-C₂₀ alkoxy group, a cyclopentyl group, acyclohexyl group, a cycloheptyl group, a cyclopentenyl group, acyclohexenyl group, a phenyl group, a pentalenyl group, an indenylgroup, a naphthyl group, an azulenyl group, a heptalenyl group, anindacenyl group, an acenaphthyl group, a fluorenyl group, aspiro-fluorenyl group, a benzofluorenyl group, a dibenzofluorenyl group,a phenalenyl group, a phenanthrenyl group, an anthracenyl group, afluoranthenyl group, a triphenylenyl group, a pyrenyl group, a chrysenylgroup, a naphthacenyl group, a picenyl group, a perylenyl group, apentaphenyl group, a hexacenyl group, a pentacenyl group, a rubicenylgroup, a coronenyl group, an ovalenyl group, a pyrrolyl group, athiophenyl group, a furanyl group, an imidazolyl group, a pyrazolylgroup, a thiazolyl group, an isothiazolyl group, an oxazolyl group, anisoxazolyl group, a pyridinyl group, a pyrazinyl group, a pyrimidinylgroup, a pyridazinyl group, an isoindolyl group, an indolyl group, anindazolyl group, a purinyl group, a quinolinyl group, an isoquinolinylgroup, a benzoquinolinyl group, a phthalazinyl group, a naphthyridinylgroup, a quinoxalinyl group, a quinazolinyl group, a cinnolinyl group, acarbazolyl group, a phenanthridinyl group, an acridinyl group, aphenanthrolinyl group, a phenazinyl group, a benzoimidazolyl group, abenzofuranyl group, a benzothiophenyl group, an isobenzothiazolyl group,a benzoxazolyl group, an isobenzoxazolyl group, a triazolyl group, atetrazolyl group, an oxadiazolyl group, a triazinyl group, adibenzofuranyl group, a dibenzothiophenyl group, a benzocarbazolylgroup, a dibenzocarbazolyl group, a thiadiazolyl group, animidazopyridinyl group, and an imidazopyrimidinyl group.
 4. Thecondensed cyclic compound as claimed in claim 1, wherein L₁ and L₂ areeach independently a group represented by one of the following Formulae3-1 to 3-38:

wherein, in Formulae 3-1 to 3-38, Y₁ is O, S, C(Z₃)(Z₄), N(Z₅), orSi(Z₆)(Z₇); Z₁ to Z₇ are each independently selected from a hydrogen, adeuterium, —F, —Cl, —Br, —I, a hydroxyl group, a cyano group, a nitrogroup, an amino group, an amidino group, a hydrazine group, a hydrazonegroup, a carboxylic acid or a salt thereof, a sulfonic acid or a saltthereof, a phosphoric acid or a salt thereof, a C₁-C₂₀ alkyl group, aC₁-C₂₀ alkoxy group, a phenyl group, a naphthyl group, a fluorenylgroup, a spiro-fluorenyl group, a benzofluorenyl group, adibenzofluorenyl group, a phenanthrenyl group, an anthracenyl group, apyrenyl group, a chrysenyl group, a pyridinyl group, a pyrazinyl group,a pyrimidinyl group, a pyridazinyl group, a quinolinyl group, anisoquinolinyl group, a quinoxalinyl group, a quinazolinyl group, acarbazolyl group, and a triazinyl group; d1 is an integer selected from1 to 4, d2 is an integer selected from 1 to 3, d3 is an integer selectedfrom 1 to 6, d4 is an integer selected from 1 to 8, d5 is an integer of1 or 2, d6 is an integer selected from 1 to 5, and * and *′ are eachindependently a binding site to a neighboring atom.
 5. The condensedcyclic compound as claimed in claim 1, wherein L₁ and L₂ are eachindependently selected from: a phenylene group, a naphthylene group, apyridinylene group, a pyrimidinylene group, a quinolinylene group, aquinoxalinylene group, and a triazinylene group; and a phenylene group,a naphthylene group, a pyridinylene group, a pyrimidinylene group, aquinolinylene group, a quinoxalinylene group, and a triazinylene group,each substituted with at least one selected from a hydrogen, adeuterium, —F, —Cl, —Br, —I, a hydroxyl group, a cyano group, a nitrogroup, an amino group, an amidino group, a hydrazine group, a hydrazonegroup, a carboxylic acid or a salt thereof, a sulfonic acid or a saltthereof, a phosphoric acid or a salt thereof, a C₁-C₂₀ alkyl group, aC₁-C₂₀ alkoxy group, a phenyl group, a naphthyl group, a fluorenylgroup, a spiro-fluorenyl group, a benzofluorenyl group, adibenzofluorenyl group, a phenanthrenyl group, an anthracenyl group, apyrenyl group, a chrysenyl group, a pyridinyl group, a pyrazinyl group,a pyrimidinyl group, a pyridazinyl group, a quinolinyl group, anisoquinolinyl group, a quinoxalinyl group, a quinazolinyl group, acarbazolyl group, and a triazinyl group.
 6. The condensed cycliccompound as claimed in claim 1, wherein b1 and b2 are each independentlyselected from 0, 1, and
 2. 7. The condensed cyclic compound as claimedin claim 1, wherein Ar₁ is selected from: a phenyl group, a pentalenylgroup, an indenyl group, a naphthyl group, an azulenyl group, aheptalenyl group, an indacenyl group, an acenaphthyl group, a fluorenylgroup, a spiro-fluorenyl group, a benzofluorenyl group, adibenzofluorenyl group, a phenalenyl group, a phenanthrenyl group, ananthracenyl group, a fluoranthenyl group, a pyrenyl group, a chrysenylgroup, a naphthacenyl group, a picenyl group, a perylenyl group, apentaphenyl group, a hexacenyl group, a pentacenyl group, a rubicenylgroup, a coronenyl group, an ovalenyl group, a pyrrolyl group, athiophenyl group, a furanyl group, an imidazolyl group, a pyrazolylgroup, a thiazolyl group, an isothiazolyl group, an oxazolyl group, anisoxazolyl group, a pyridinyl group, a pyrazinyl group, a pyrimidinylgroup, a pyridazinyl group, an isoindolyl group, an indolyl group, anindazolyl group, a purinyl group, a quinolinyl group, an isoquinolinylgroup, a benzoquinolinyl group, a phthalazinyl group, a naphthyridinylgroup, a quinoxalinyl group, a quinazolinyl group, a cinnolinyl group, acarbazolyl group, a phenanthridinyl group, an acridinyl group, aphenanthrolinyl group, a phenazinyl group, a benzoimidazolyl group, abenzofuranyl group, a benzothiophenyl group, an isobenzothiazolyl group,a benzoxazolyl group, an isobenzoxazolyl group, a triazolyl group, atetrazolyl group, an oxadiazolyl group, a triazinyl group, abenzocarbazolyl group, a dibenzocarbazolyl group, a thiadiazolyl group,an imidazopyridinyl group, and an imidazopyrimidinyl group; and a phenylgroup, a pentalenyl group, an indenyl group, a naphthyl group, anazulenyl group, a heptalenyl group, an indacenyl group, an acenaphthylgroup, a fluorenyl group, a spiro-fluorenyl group, a benzofluorenylgroup, a dibenzofluorenyl group, a phenalenyl group, a phenanthrenylgroup, an anthracenyl group, a fluoranthenyl group, a pyrenyl group, achrysenyl group, a naphthacenyl group, a picenyl group, a perylenylgroup, a pentaphenyl group, a hexacenyl group, a pentacenyl group, arubicenyl group, a coronenyl group, an ovalenyl group, a pyrrolyl group,a thiophenyl group, a furanyl group, an imidazolyl group, a pyrazolylgroup, a thiazolyl group, an isothiazolyl group, an oxazolyl group, anisoxazolyl group, a pyridinyl group, a pyrazinyl group, a pyrimidinylgroup, a pyridazinyl group, an isoindolyl group, an indolyl group, anindazolyl group, a purinyl group, a quinolinyl group, an isoquinolinylgroup, a benzoquinolinyl group, a phthalazinyl group, a naphthyridinylgroup, a quinoxalinyl group, a quinazolinyl group, a cinnolinyl group, acarbazolyl group, a phenanthridinyl group, an acridinyl group, aphenanthrolinyl group, a phenazinyl group, a benzoimidazolyl group, abenzofuranyl group, a benzothiophenyl group, an isobenzothiazolyl group,a benzoxazolyl group, an isobenzoxazolyl group, a triazolyl group, atetrazolyl group, an oxadiazolyl group, a triazinyl group, abenzocarbazolyl group, a dibenzocarbazolyl group, a thiadiazolyl group,an imidazopyridinyl group, and an imidazopyrimidinyl group, eachsubstituted with at least one selected from a deuterium, —F, —Cl, —Br,—I, a hydroxyl group, a cyano group, a nitro group, an amino group, anamidino group, a hydrazine group, a hydrazone group, a carboxylic acidor a salt thereof, a sulfonic acid or a salt thereof, a phosphoric acidor a salt thereof, a C₁-C₂₀ alkyl group, a C₁-C₂₀ alkoxy group, acyclopentyl group, a cyclohexyl group, a cycloheptyl group, acyclopentenyl group, a cyclohexenyl group, a phenyl group, a pentalenylgroup, an indenyl group, a naphthyl group, an azulenyl group, aheptalenyl group, an indacenyl group, an acenaphthyl group, a fluorenylgroup, a spiro-fluorenyl group, a benzofluorenyl group, adibenzofluorenyl group, a phenalenyl group, a phenanthrenyl group, ananthracenyl group, a fluoranthenyl group, a pyrenyl group, a chrysenylgroup, a naphthacenyl group, a picenyl group, a perylenyl group, apentaphenyl group, a hexacenyl group, a pentacenyl group, a rubicenylgroup, a coronenyl group, an ovalenyl group, a pyrrolyl group, athiophenyl group, a furanyl group, an imidazolyl group, a pyrazolylgroup, a thiazolyl group, an isothiazolyl group, an oxazolyl group, anisoxazolyl group, a pyridinyl group, a pyrazinyl group, a pyrimidinylgroup, a pyridazinyl group, an isoindolyl group, an indolyl group, anindazolyl group, a purinyl group, a quinolinyl group, an isoquinolinylgroup, a benzoquinolinyl group, a phthalazinyl group, a naphthyridinylgroup, a quinoxalinyl group, a quinazolinyl group, a cinnolinyl group, acarbazolyl group, a phenanthridinyl group, an acridinyl group, aphenanthrolinyl group, a phenazinyl group, a benzoimidazolyl group, abenzofuranyl group, a benzothiophenyl group, an isobenzothiazolyl group,a benzoxazolyl group, an isobenzoxazolyl group, a triazolyl group, atetrazolyl group, an oxadiazolyl group, a triazinyl group, abenzocarbazolyl group, a dibenzocarbazolyl group, a thiadiazolyl group,an imidazopyridinyl group, an imidazopyrimidinyl group, and—Si(Q₃₁)(Q₃₂)(Q₃₃), wherein Q₃₁ to Q₃₃ are each independently selectedfrom a hydrogen, a deuterium, —F, —Cl, —Br, —I, a hydroxyl group, acyano group, a nitro group, an amino group, an amidino group, ahydrazine group, a hydrazone group, a carboxylic acid or a salt thereof,a sulfonic acid or a salt thereof, a phosphoric acid or a salt thereof,a C₁-C₂₀ alkyl group, a C₁-C₂₀ alkoxy group, a phenyl group, a naphthylgroup, a fluorenyl group, a spiro-fluorenyl group, a benzofluorenylgroup, a dibenzofluorenyl group, a phenanthrenyl group, an anthracenylgroup, a pyrenyl group, a chrysenyl group, a pyridinyl group, apyrazinyl group, a pyrimidinyl group, a pyridazinyl group, a quinolinylgroup, an isoquinolinyl group, a quinoxalinyl group, a quinazolinylgroup, a carbazolyl group, and a triazinyl group.
 8. The condensedcyclic compound as claimed in claim 1, wherein Ar₁ is selected from: aphenyl group, a naphthyl group, a fluorenyl group, a spiro-fluorenylgroup, a benzofluorenyl group, a dibenzofluorenyl group, a phenanthrenylgroup, an anthracenyl group, a pyrenyl group, a chrysenyl group, apyridinyl group, a pyrazinyl group, a pyrimidinyl group, a pyridazinylgroup, a quinolinyl group, an isoquinolinyl group, a quinoxalinyl group,a quinazolinyl group, a carbazolyl group, a triazinyl group, abenzocarbazolyl group, and a dibenzocarbazolyl group; and a phenylgroup, a naphthyl group, a fluorenyl group, a spiro-fluorenyl group, abenzofluorenyl group, a dibenzofluorenyl group, a phenanthrenyl group,an anthracenyl group, a pyrenyl group, a chrysenyl group, a pyridinylgroup, a pyrazinyl group, a pyrimidinyl group, a pyridazinyl group, aquinolinyl group, an isoquinolinyl group, a quinoxalinyl group, aquinazolinyl group, a carbazolyl group, a triazinyl group, abenzocarbazolyl group, and a dibenzocarbazolyl group, each substitutedwith at least one selected from a deuterium, —F, —Cl, —Br, —I, ahydroxyl group, a cyano group, a nitro group, an amino group, an amidinogroup, a hydrazine group, a hydrazone group, a carboxylic acid or a saltthereof, a sulfonic acid or a salt thereof, a phosphoric acid or a saltthereof, a C₁-C₂₀ alkyl group, a C₁-C₂₀ alkoxy group, a phenyl group, anaphthyl group, a fluorenyl group, a spiro-fluorenyl group, abenzofluorenyl group, a dibenzofluorenyl group, a phenanthrenyl group,an anthracenyl group, a pyrenyl group, a chrysenyl group, a pyridinylgroup, a pyrazinyl group, a pyrimidinyl group, a pyridazinyl group, aquinolinyl group, an isoquinolinyl group, a quinoxalinyl group, aquinazolinyl group, a carbazolyl group, a triazinyl group, abenzocarbazolyl group, a dibenzocarbazolyl group, and—Si(Q₃₁)(Q₃₂)(Q₃₃), wherein Q₃₁ to Q₃₃ are each independently selectedfrom a hydrogen, a deuterium, —F, —Cl, —Br, —I, a hydroxyl group, acyano group, a nitro group, an amino group, an amidino group, ahydrazine group, a hydrazone group, a carboxylic acid or a salt thereof,a sulfonic acid or a salt thereof, a phosphoric acid or a salt thereof,a C₁-C₂₀ alkyl group, a C₁-C₂₀ alkoxy group, a phenyl group, a naphthylgroup, a fluorenyl group, a spiro-fluorenyl group, a benzofluorenylgroup, a dibenzofluorenyl group, a phenanthrenyl group, an anthracenylgroup, a pyrenyl group, a chrysenyl group, a pyridinyl group, apyrazinyl group, a pyrimidinyl group, a pyridazinyl group, a quinolinylgroup, an isoquinolinyl group, a quinoxalinyl group, a quinazolinylgroup, a carbazolyl group, and a triazinyl group.
 9. The condensedcyclic compound as claimed in claim 1, wherein Ar1 is a grouprepresented by one of the following Formulae 5-1 to 5-15:

wherein, in Formulae 5-1 to 5-15, Y₃₁ is C(Z₃₃)(Z₃₄) or N(Z₃₅); Z₃₁ toZ₃₅ are each independently selected from: a hydrogen, a deuterium, —F,—Cl, —Br, —I, a hydroxyl group, a cyano group, a nitro group, an aminogroup, an amidino group, a hydrazine group, a hydrazone group, acarboxylic acid or a salt thereof, a sulfonic acid or a salt thereof, aphosphoric acid or a salt thereof, a C₁-C₂₀ alkyl group, and a C₁-C₂₀alkoxy group; a C₁-C₂₀ alkyl group and a C₁-C₂₀ alkoxy group, eachsubstituted with at least one selected from a deuterium, —F, —Cl, —Br,—I, a hydroxyl group, a cyano group, a nitro group, an amino group, anamidino group, a hydrazine group, a hydrazone group, a carboxylic acidor a salt thereof, a sulfonic acid or a salt thereof, and a phosphoricacid or a salt thereof; a phenyl group, a naphthyl group, a fluorenylgroup, a spiro-fluorenyl group, a benzofluorenyl group, adibenzofluorenyl group, a phenanthrenyl group, an anthracenyl group, apyrenyl group, a chrysenyl group, a pyridinyl group, a pyrazinyl group,a pyrimidinyl group, a pyridazinyl group, a quinolinyl group, anisoquinolinyl group, a quinoxalinyl group, a quinazolinyl group, acarbazolyl group, a triazinyl group, a benzocarbazolyl group, and adibenzocarbazolyl group; a phenyl group, a naphthyl group, a fluorenylgroup, a spiro-fluorenyl group, a benzofluorenyl group, adibenzofluorenyl group, a phenanthrenyl group, an anthracenyl group, apyrenyl group, a chrysenyl group, a pyridinyl group, a pyrazinyl group,a pyrimidinyl group, a pyridazinyl group, a quinolinyl group, anisoquinolinyl group, a quinoxalinyl group, a quinazolinyl group, acarbazolyl group, a triazinyl group, a benzocarbazolyl group, and adibenzocarbazolyl group, each substituted with at least one selectedfrom a deuterium, —F, —Cl, —Br, —I, a hydroxyl group, a cyano group, anitro group, an amino group, an amidino group, a hydrazine group, ahydrazone group, a carboxylic acid or a salt thereof, a sulfonic acid ora salt thereof, a phosphoric acid or a salt thereof, a C₁-C₂₀ alkylgroup, a C₁-C₂₀ alkoxy group, a phenyl group, and a naphthyl group; and—Si(Q₃₁)(Q₃₂)(Q₃₃), wherein Q₃₁ to Q₃₃ are each independently selectedfrom a hydrogen, a deuterium, —F, —Cl, —Br, —I, a hydroxyl group, acyano group, a nitro group, an amino group, an amidino group, ahydrazine group, a hydrazone group, a carboxylic acid or a salt thereof,a sulfonic acid or a salt thereof, a phosphoric acid or a salt thereof,a C₁-C₂₀ alkyl group, a C₁-C₂₀ alkoxy group, a phenyl group, a naphthylgroup, a fluorenyl group, a spiro-fluorenyl group, a benzofluorenylgroup, a dibenzofluorenyl group, a phenanthrenyl group, an anthracenylgroup, a pyrenyl group, a chrysenyl group, a pyridinyl group, apyrazinyl group, a pyrimidinyl group, a pyridazinyl group, a quinolinylgroup, an isoquinolinyl group, a quinoxalinyl group, a quinazolinylgroup, a carbazolyl group, and a triazinyl group; e1 is an integerselected from 1 to 5, e2 is an integer selected from 1 to 7, e3 is aninteger selected from 1 to 3, e4 is an integer selected from 1 to 4, e5is an integer of 1 or 2, and * is a binding site to a neighboring atom.10. The condensed cyclic compound as claimed in claim 1, wherein Ar₁ isa group represented by one of the following Formulae 6-1 to 6-24:

wherein, in Formulae 6-1 to 6-24, * is a binding site to a neighboringatom.
 11. The condensed cyclic compound as claimed in claim 1, whereinR₁ to R₁₂ and R₂₁ to R₃₂ are each independently selected from: a bindingsite to one of A₁, L₁, and A₂ in Formula 1; a hydrogen, a deuterium, —F,—Cl, —Br, —I, a hydroxyl group, a cyano group, a nitro group, an aminogroup, an amidino group, a hydrazine group, a hydrazone group, acarboxylic acid or a salt thereof, a sulfonic acid or a salt thereof, aphosphoric acid or a salt thereof, a C₁-C₂₀ alkyl group, and a C₁-C₂₀alkoxy group; a C₁-C₂₀ alkyl group and a C₁-C₂₀ alkoxy group, eachsubstituted with at least one selected from a deuterium, —F, —Cl, —Br,—I, a hydroxyl group, a cyano group, a nitro group, an amino group, anamidino group, a hydrazine group, a hydrazone group, a carboxylic acidor a salt thereof, a sulfonic acid or a salt thereof, a phosphoric acidor a salt thereof, a phenyl group, a naphthyl group, a pyridinyl group,and a pyrimidinyl group; a phenyl group, a naphthyl group, a fluorenylgroup, a phenanthrenyl group, an anthracenyl group, a fluoranthenylgroup, a triphenylenyl group, a pyrenyl group, a chrysenyl group, apyrrolyl group, a thiophenyl group, a furanyl group, an imidazolylgroup, a pyrazolyl group, a thiazolyl group, an isothiazolyl group, anoxazolyl group, an isoxazolyl group, a pyridinyl group, a pyrazinylgroup, a pyrimidinyl group, a pyridazinyl group, an isoindolyl group, anindolyl group, an indazolyl group, a purinyl group, a quinolinyl group,an isoquinolinyl group, a benzoquinolinyl group, a quinoxalinyl group, aquinazolinyl group, a cinnolinyl group, a carbazolyl group, aphenanthrolinyl group, a benzoimidazolyl group, a benzofuranyl group, abenzothiophenyl group, an isobenzothiazolyl group, a benzoxazolyl group,an isobenzoxazolyl group, a triazolyl group, a tetrazolyl group, anoxadiazolyl group, a triazinyl group, a dibenzofuranyl group, adibenzothiophenyl group, a benzocarbazolyl group, a dibenzocarbazolylgroup, an imidazopyridinyl group, and an imidazopyrimidinyl group; aphenyl group, a naphthyl group, a fluorenyl group, a phenanthrenylgroup, an anthracenyl group, a fluoranthenyl group, a triphenylenylgroup, a pyrenyl group, a chrysenyl group, a pyrrolyl group, athiophenyl group, a furanyl group, an imidazolyl group, a pyrazolylgroup, a thiazolyl group, an isothiazolyl group, an oxazolyl group, anisoxazolyl group, a pyridinyl group, a pyrazinyl group, a pyrimidinylgroup, a pyridazinyl group, an isoindolyl group, an indolyl group, anindazolyl group, a purinyl group, a quinolinyl group, an isoquinolinylgroup, a benzoquinolinyl group, a quinoxalinyl group, a quinazolinylgroup, a cinnolinyl group, a carbazolyl group, a phenanthrolinyl group,a benzoimidazolyl group, a benzofuranyl group, a benzothiophenyl group,an isobenzothiazolyl group, a benzoxazolyl group, an isobenzoxazolylgroup, a triazolyl group, a tetrazolyl group, an oxadiazolyl group, atriazinyl group, a dibenzofuranyl group, a dibenzothiophenyl group, abenzocarbazolyl group, a dibenzocarbazolyl group, an imidazopyridinylgroup, and an imidazopyrimidinyl group, each substituted with at leastone selected from a deuterium, —F, —Cl, —Br, —I, a hydroxyl group, acyano group, a nitro group, an amino group, an amidino group, ahydrazine group, a hydrazone group, a carboxylic acid or a salt thereof,a sulfonic acid or a salt thereof, a phosphoric acid or a salt thereof,a C₁-C₂₀ alkyl group, a C₁-C₂₀ alkoxy group, a phenyl group, a naphthylgroup, a fluorenyl group, a phenanthrenyl group, an anthracenyl group, afluoranthenyl group, a triphenylenyl group, a pyrenyl group, a chrysenylgroup, a pyrrolyl group, a thiophenyl group, a furanyl group, animidazolyl group, a pyrazolyl group, a thiazolyl group, an isothiazolylgroup, an oxazolyl group, an isoxazolyl group, a pyridinyl group, apyrazinyl group, a pyrimidinyl group, a pyridazinyl group, an isoindolylgroup, an indolyl group, an indazolyl group, a purinyl group, aquinolinyl group, an isoquinolinyl group, a benzoquinolinyl group, aquinoxalinyl group, a quinazolinyl group, a cinnolinyl group, acarbazolyl group, a phenanthrolinyl group, a benzoimidazolyl group, abenzofuranyl group, a benzothiophenyl group, an isobenzothiazolyl group,a benzoxazolyl group, an isobenzoxazolyl group, a triazolyl group, atetrazolyl group, an oxadiazolyl group, a triazinyl group, adibenzofuranyl group, a dibenzothiophenyl group, a benzocarbazolylgroup, a dibenzocarbazolyl group, an imidazopyridinyl group, animidazopyrimidinyl group, and —Si(Q₃₁)(Q₃₂)(Q₃₃); and —Si(Q₁)(Q₂)(Q₃),wherein one of R₁ to R₁₂ is a binding site to L₁ or A₂ in Formula 1, andone of R₂₁ to R₃₂ is a binding site to L₁ or A₁ in Formula
 1. 12. Thecondensed cyclic compound as claimed in claim 1, wherein R₁ to R₁₂ andR₂₁ to R₃₂ are each independently selected from: a binding site to oneof A₁, L₁, and A₂ in Formula 1; a hydrogen, —F, a cyano group, a nitrogroup, a methyl group, an ethyl group, a propyl group, an n-butyl group,an iso-butyl group, a sec-butyl group, a tert-butyl group, an n-pentylgroup, an iso-pentyl group, a sec-pentyl group, a tert-pentyl group, ann-hexyl group, an iso-hexyl group, a sec-hexyl group, a tert-hexylgroup, an n-heptyl group, an iso-heptyl group, a sec-heptyl group, atert-heptyl group, an n-octyl group, an iso-octyl group, a sec-octylgroup, a tert-octyl group, an n-nonyl group, an iso-nonyl group, asec-nonyl group, a tert-nonyl group, an n-decanyl group, an isodecanylgroup, a sec-decanyl group, a tert-decanyl group, a methoxy group, anethoxy group, a propoxy group, a butoxy group, a pentoxy group, a phenylgroup, a naphthyl group, a pyridinyl group, a pyrimidinyl group, and atriazinyl group; a methyl group, an ethyl group, a propyl group, ann-butyl group, an iso-butyl group, a sec-butyl group, a tert-butylgroup, an n-pentyl group, an iso-pentyl group, a sec-pentyl group, atert-pentyl group, an n-hexyl group, an iso-hexyl group, a sec-hexylgroup, a tert-hexyl group, an n-heptyl group, an iso-heptyl group, asec-heptyl group, a tert-heptyl group, an n-octyl group, an iso-octylgroup, a sec-octyl group, a tert-octyl group, an n-nonyl group, aniso-nonyl group, a sec-nonyl group, a tert-nonyl group, an n-decanylgroup, an isodecanyl group, a sec-decanyl group, a tert-decanyl group, amethoxy group, an ethoxy group, a propoxy group, a butoxy group, apentoxy group, a phenyl group, a naphthyl group, a pyridinyl group, apyrimidinyl group, and a triazinyl group, each substituted with at leastone selected from —F, a cyano group, a nitro group, a phenyl group, anaphthyl group, a pyridinyl group, a pyrimidinyl group, a triazinylgroup, and —Si(Q₃₁)(Q₃₂)(Q₃₃); and —Si(Q₁)(Q₂)(Q₃), wherein one of R₁ toR₁₂ is a binding site to L₁ or A₂ in Formula 1, and one of R₂₁ to R₃₂ isa binding site to L₁ or A₁ in Formula
 1. 13. The condensed cycliccompound as claimed in claim 1, wherein the compound represented byFormula 1 is represented by one of the following Formulae 1A to 1L:

wherein, in Formulae 1A to 1L, the descriptions of L₁, L₂, b1, b2, Ar₁,R₁ to R₁₂, and R₂₁ to R₃₂ are the same as L₁, L₂, b1, b2, Ar₁, R₁ toR₁₂, and R₂₁ to R₃₂ of Formulae 1, 2-1, and 2-2.
 14. The condensedcyclic compound as claimed in claim 13, wherein, in Formulae 1A to 1L,b1 and b2 are each independently selected from 0, 1, and 2, and L₁ andL₂ are each independently a group represented by one of the followingFormulae 4-1 to 4-20,

wherein, in Formulae 4-1 to 4-20, * and *′ are a binding site to aneighboring atom.
 15. The condensed cyclic compound as claimed in claim13, wherein: Ar₁ is a group represented by one of the following Formulae6-1 to 6-19, and R₁ to R₁₂ and R₂₁ to R₃₂ are each independently a grouprepresented by one of the following Formulae 7-1 to 7-6:

wherein, in Formulae 6-1 to 6-19 and 7-1 to 7-6, * is a binding site toa neighboring atom.
 16. The condensed cyclic compound as claimed inclaim 1, wherein the compound represented by Formula 1 is one of thefollowing Compounds 1 to 75:


17. An organic light-emitting device, comprising: a first electrode; asecond electrode facing the first electrode; and an organic layerbetween the first electrode and the second electrode, the organic layerincluding an emission layer, wherein the organic layer includes thecondensed cyclic compound as claimed in claim
 1. 18. The organiclight-emitting device as claimed in claim 17, wherein: the firstelectrode is an anode, the second electrode is a cathode, and theorganic layer includes: a hole transport region between the firstelectrode and the emission layer, the hole transport region including atleast one of a hole injection layer, a hole transport layer, a bufferlayer, and an electron blocking layer, and an electron transport regionbetween the emission layer and the second electrode, the electrontransport region including at least one of a hole blocking layer, anelectron transport layer, and an electron injection layer.
 19. Theorganic light-emitting device as claimed in claim 17, wherein theemission layer includes the condensed cyclic compound.
 20. The organiclight-emitting device as claimed in claim 19, wherein the emission layerfurther includes a dopant.